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This is the material plane 
And every outward thing we do is inner work 
Coleman Barks 
 
 
 
 
 
 
 
 
 
This we have now 
is not imagination. 
This is not grief, 
or joy, not a judging state,  
or an elation, or a sadness. 
Those come and go. 
This is the presence 
that doesn’t. 
Jalaluddin Rumi (1207 -1273) 
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Summary
Background: During the last decades there has been a shift away from the traditional view 
of health care professionals as the only experts and providers of knowledge and the patients 
as passive recipients, to a more collaborative approach, recognizing the patient as an active 
agent in managing illness and own health care. Within the health care system, one has 
gained a broader understanding of the complex interaction between person and disease and 
realized that a narrow biomedical approach is inadequate. Although pharmacological 
treatment for patients with rheumatic diseases has developed remarkably, not all patients are 
eligible for the new medications, the disease process is still only partly controllable, and 
many patients need to make demanding lifestyle changes. There is therefore a need for non-
pharmacological interventions that enhance individuals’ coping abilities and help them to 
adjust to living with a lifelong disease. 
The Vitality Training Programme (VTP) is a group intervention that aims at enhancing 
people’s health promoting resources, their capacity to engage in the process of everyday 
living and ability to live a meaningful and valued life. Rather than focusing on strategies to 
control or reduce symptoms, the VTP explicitly emphasises the importance of non-
judgemental attention to thoughts, feelings and bodily senses without attempting to avoid or 
change them. Beneficial effects have been documented in persons with chronic 
musculoskeletal pain, but the VTP has previously not been evaluated in persons with 
inflammatory rheumatic diseases. 
Aims: The main aims of this research project were: 1) to evaluate effects of the VTP on 
psychological wellbeing, coping and disease-related symptoms in patients with chronic 
rheumatic diseases, 2) to explore participants' VTP experiences, and 3) to test the 
measurement properties of an instrument to measure emotion-focused coping, the Emotional 
Approach Coping Scale (EAC), in Norwegian patients with rheumatic diseases. 
Materials and methods: First, persons with various inflammatory arthritides (IA) and 
fibromyalgia syndrome (FMS), who attended the VTP at six rheumatology departments, 
were included in a prospective pre – post-test study with one-year follow-up (n = 175). 
Participants in the first ten groups were also asked to take part in qualitative focus group 
interviews (n = 69). Second, the Emotional Approach Coping Scale (EAC) was translated to 
Norwegian and tested in three different samples, a consecutive sample of patients attending 
rheumatology clinics (n = 118), a sample of patients attending the VTP (n = 36), and a 
sample attending a self-management program at a rheumatology hospital (n = 66). All 
patients had confirmed rheumatologic diagnoses of at least 0.5 years duration. Validity was 
tested in a cross-sectional study including all three samples, whereas responsiveness was 
tested in the two intervention groups. Finally, persons with inflammatory rheumatic joint 
diseases were recruited to a randomised controlled trial and allocated to either the VTP (n = 
36) or routine care control plus a CD with mindfulness-based home exercises (n = 35). 
Qualitative data, collected from the focus group interviews were analysed by a qualitative 
content approach (paper II). Quantitative data were collected by self-report questionnaires 
and analysed by a variety of statistical methods, including paired t-tests for within-group 
changes (papers I, and III), bivariate and multivariate regression analyses of predictions 
(paper I), principal component factor analysis and correlation statistics (paper III), and 
mixed models repeated measures analyses of between-group effects (paper IV). Effect sizes 
were estimated by standardised response mean (SRM) (paper I and III) and by Cohen’s d 
statistic (paper IV). 
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Results: In the pre – post-test study, psychological distress, wellbeing, self-efficacy pain and 
symptoms and self-care ability were significantly improved in IA patients post-intervention, 
and the improvements were maintained at one-year follow-up (all p-values < 0.001). The 
SRMs ranged from 0.63 (wellbeing) to 0.41 (self-care ability). No significant reduction was 
found in fatigue after intervention, but at one-year follow-up fatigue was significantly 
reduced in IA patients (p = 0.007). No statistically significant improvements were found in 
any variables in patients with FMS. Inflammatory diagnosis and higher scores of fatigue at 
baseline were the main predictors of reduction in psychological distress at one-year follow-
up. 
Participants in the focus groups described how the VTP had helped them to recognize 
themselves as both ill and healthy, to recognize their emotions, and to become more aware of 
their own needs. Being part of a supportive community and being recognized as a credible 
patient had been important facilitators of their outcomes. 
The EAC had low levels of missing data, and results from principal component analysis 
supported the two subscales, Emotional Processing and Emotional Expression, which both 
had high Cronbach's alphas of 0.92 and 0.90, respectively. Both EAC Processing and EAC 
Expression increased significantly in the VTP group after intervention (p-values < 0.05), 
whereas there were no significant changes in the EAC scales in the self-management sample 
at follow-up. 
In the randomised controlled trial, significant treatment effects in favour of the VTP group 
were found post-treatment, and effects were maintained at 12 months in psychological 
distress (effect size 0.58), self-efficacy pain (effect size 0.59) and symptoms (effect size 
0.92) and emotional processing (effect size 0.43). In the VTP group, the number of persons 
with serious psychological distress was reduced from 13 (36%) at baseline to 2 (6%) at 12 
months compared with from 10 (29%) to 8 (24%) in the control group (p = 0.045). 
Significant treatment effects in favour of the VTP group were also found post-treatment and 
at 12 months in fatigue (effect size 0.50), self-care ability (effect size 0.59) and wellbeing 
(effect size 0.43). The improvement in fatigue was increased at 12 months in the VTP group, 
whereas the control group was unchanged from baseline. Effects in pain and the patient 
global assessment of disease activity did not reach statistical significance. 
Conclusions and implications: This research project has illuminated how a process-
oriented group intervention that focuses on topics related to life rather than the disease, 
explicitly addresses disease-related emotions and combines mindfulness-based and creative 
exercises, can enhance emotional wellbeing and strengthen individuals' belief in their 
abilities to manage their symptoms. Beneficial health effects were documented in terms of 
reduced psychological distress and fatigue. The EAC was found to be a valid and responsive 
instrument for measuring emotion-focused coping in persons with rheumatic diseases.  
These results show that the VTP is a feasible intervention that should be considered as a 
beneficial complement to existing treatment for patients with inflammatory rheumatic 
diseases, particularly for people who experience heightened psychological distress and 
fatigue. 
Key-words: vitality, rheumatic diseases, psychological distress, fatigue, self-efficacy, 
coping, emotions, adjustment, mindfulness, qualitative research, repeated measurements, 
mixed models analysis 
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1. Introduction
I have been working at the National Resource Center for Rehabilitation in 
Rheumatology (NRRK) at Diakonhjemmet Hospital since the centre was founded in 
1999. During this period major changes have taken place in the field of 
rheumatology. One is the substantial advance in medical treatment that has improved 
quality of life for a large group of patients with inflammatory rheumatic diseases. 
Another is the increased focus on patient participation and inclusion of the patient 
perspective in individual health care, as well as in the overall health care system and 
research. There has been a shift from the traditional view of health care professionals 
as the only experts and providers of knowledge and patients as passive recipients, to a 
more collaborative approach, recognizing the patient as an active agent in managing 
illness and own health care. An increased understanding that a narrow biomedical 
approach is inadequate has evolved within the health care system (1-4). These 
changes have also led to a broader understanding of the complex interaction between 
person and disease. How people respond to their illness and experience their quality 
of life cannot be explained by the severity of the disease and symptoms alone, and 
existing medical treatments are not sufficient to cure or control all symptoms and 
disease processes (5;6). By listening to the patients we have learned that previous life 
experiences, personal identity, how the disease interferes with their current life 
situation, future hopes and wishes, how they perceive their abilities to cope with 
stressful events and what kind of social support they experience, have a great impact 
on how people adjust to living with chronic disease. 
The Vitality Training Programme (VTP) is a group intervention that aims at 
enhancing people’s health promoting resources, their capacity to engage in the 
process of everyday living and ability to live a meaningful and valued life. Rather 
than focusing on strategies to control or reduce symptoms, the VTP explicitly 
emphasises the importance of non-judgemental attention to thoughts, feelings and 
bodily senses without attempting to avoid or change them. Liv Haugli, an 
occupational medicine physician, and Eldri Steen, a nurse and health educator with 
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many years of counselling experience, developed the VTP in the late 1990s in close 
collaboration with people who lived with chronic musculoskeletal pain and health 
care professionals working with this group of people. The intervention was described 
and evaluated in a doctoral thesis (7). 
When I learned about Steen and Haugli’s work in 2000, I thought that the VTP might 
be a helpful intervention for people with inflammatory rheumatic diseases as well. I 
presumed that this kind of intervention would fill in a gap between existing medical 
and physical treatments for these patients, and the patients’ needs for dealing with the 
emotional and social aspects of their chronic condition. Accordingly, a telephone 
contact with Eldri Steen initiated a ten-year collaboration of adapting, implementing 
and evaluating the VTP for persons with rheumatic diseases.  
First, we adapted the VTP in collaboration with two persons who had long-term 
experience of living with inflammatory arthritis. Then we tested the program in two 
pilot groups and made further adaptations according to participants' responses. In 
parallel, group facilitators from six rheumatology departments were trained in a one-
year educational program, and from January 2003 the VTP was implemented in six 
rheumatology departments. At the same time we started a pre – post-test study of 
clinical effects of the VTP in persons with rheumatic diseases. Based on the previous 
studies by Haugli and Steen (8-11), we did not consider the VTP to be a diagnosis-
specific intervention. We therefore included a wide range of inflammatory and non-
inflammatory rheumatologic diagnoses in our first study (papers I and II). On the 
basis of these results, we realised the need for evaluating the VTP in a less 
heterogeneous group. Consequently, we included only persons with inflammatory 
rheumatic joint diseases in the last study; a randomised controlled trial (RCT). 
Recognising the importance of including patient perspectives in developing and 
evaluating interventions, we also conducted a qualitative focus group study in order 
to illuminate experiences from VTP participation. The study also revealed a need for 
measuring emotion-focused coping. We therefore translated and tested the properties 
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of an instrument called the Emotional Approach Coping Scale (EAC) in Norwegian 
patients with rheumatic diseases. 
The present thesis comprises the qualitative study of experiences from VTP 
participation, the methodological study of EAC measurement properties and the 
evaluation of clinical effects of the VTP in persons with chronic rheumatic diseases. 
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2. Background
2.1 Rheumatic diseases 
Rheumatic diseases include diseases and painful conditions in the joints and 
musculoskeletal system and the connective tissues. They can be categorised into four 
main groups: 1) inflammatory rheumatic joint diseases, 2) systemic rheumatic 
diseases, 3) osteoarthritis and 4) local and generalised pain conditions (for example 
fibromyalgia syndrome) (12). The main groups of diagnoses included in this thesis 
are inflammatory rheumatic joint diseases and fibromyalgia syndrome. These 
diagnoses will therefore be further described. 
2.1.1 Inflammatory rheumatic joint diseases 
The inflammatory rheumatic joint diseases include the diagnoses rheumatoid arthritis 
(RA), juvenile ideopatic arthritis (JIA), ankylosing spondylitis (AS), psoriatic 
arthritis (PsA), and inflammatory bowel diseases-related arthritis. RA affects 
approximately 0.5 – 1% of the northern European and North American populations 
(13;14), AS approximately 0.1 - 0.2% (15;16) and PsA approximately 0.2 - 1% 
(17;18). RA affects more women than men with a ratio between 4:1 and 5:1 below 
the age of 50 and 3:1 above the age of 50 (13). AS affects more men than women 
with a ratio of between 3:1 to 2:1 (15;16), and PsA has an equal gender frequency 
(19). Although the pathogeneses of the diseases differ between, as well as within the 
diagnostic groups, they all have a systemic inflammatory component considered to be 
of an autoimmune nature (14). The inflammatory process causes various degrees of 
joint destructions, pain, swelling and stiffness. RA may affect almost all joints, but 
particularly hands, wrists and feet (14), whereas AS typically affects spinal joints 
(15;16) and PsA may involve both large joints and the spine. PsA is also associated 
with skin-related physical effects; psoriasis (18;19).  
 19
The inflammatory rheumatic joint diseases have great impact on all aspects of life. In 
addition to joint affections, the disease-induced inflammatory process can mediate 
more general physiological and psychological symptoms. Among other factors the 
autoimmune reaction involves pro-inflammatory cytokines (e.g. TNF-, interleukin 1 
and interleukin 6). These cytokines seem to promote a constellation of non-specific 
responses, such as vital exhaustion with loss of energy, inability to concentrate, 
increased irritability, depressed mood, decreased activity and reduced appetite, which 
are normal reactions when the human organism fights acute infection. This 
constellation of symptoms, referred to as ‘sickness behaviour’ (6;20), may also be 
experienced by people with chronic inflammation, and may be one of the 
mechanisms associated with fatigue in inflammatory rheumatic diseases (21).  
Patients with RA frequently report pain as their most disabling symptom (22;23) and 
have ranked pain as the most important symptom to be improved (24). There has also 
been an increasing awareness of the significance of fatigue in persons with 
inflammatory arthritis (IA), and fatigue is considered a major obstacle to optimal 
function (25) with an impact similar to pain (19;26-33). Moreover, several studies 
have shown that inflammatory rheumatic diseases are associated with impaired 
functional ability, reduced emotional wellbeing, and loss of social activities 
(19;22;23;32;34-37). The relationship between disease activity and its physical and 
psychosocial impact is not one-dimensional. There seem to be a complex interplay 
between biological, psychological and social factors (5;38). 
During the last decade, RA treatment has changed remarkably. The progress in 
understanding the pathogenesis has led to development of biological therapies and 
better targeted use of traditional disease-modifying anti-rheumatic drugs (DMARDs). 
These changes have resulted in substantial improvements in many patients' quality of 
life (QoL) (14;39;40). In later years, these therapies have also become available for 
patients with AS and PsA (41-46). However, the treatment strategies are more 
effective in patients with recent onset than in patients with established disease, and 
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not all patients are eligible for the new medications. Thus, for several patients, the 
disease process is still only partly controllable (39;47). 
In addition to the pharmacological treatment, there is considerable evidence for the 
beneficial effects of physical training in patients with RA and AS. Currently, there is 
an agreement that physical activity enhances fitness, muscle strength and functional 
ability, without negative effects on disease activity (48;49). There is also evidence 
that physical exercise inhibits production of pro-inflammatory cytokines and is 
associated with improved emotional status in patients with RA. The physical training 
should be individually designed and initially be supervised by a physiotherapist (50).  
2.1.2 Fibromyalgia syndrome 
Fibromyalgia syndrome (FMS) is characterised by chronic widespread pain and a 
range of other symptoms, such as fatigue, sleep disturbance, functional impairments, 
stiffness, depression, anxiety and irritable bowel syndrome (51-53). Pain and fatigue 
are most frequent and disabling, and the reported levels of these symptoms are 
generally higher than in patients with IA (54). FMS varies in severity, but most 
patients report reduced QoL and difficulty with routine daily activities, and 30 to 
40% have to stop work or change employment (55). Physical function is usually 
impaired and mental health scores are reduced compared to both normal healthy 
controls and other rheumatic diseases, such as RA and osteoarthritis (OA) (54;56). 
Furthermore, persons with FMS often experience disbelief about their condition, 
negative social responses and lack of understanding from family, colleagues and 
health care professionals (57). 
Because of the complexity of the FMS and the variety of symptoms, it is 
recommended that the treatment should be tailored to the individual's needs and most 
distressing symptoms. A multidisciplinary approach, combining pharmacological and 
non-pharmacological interventions is found to be the best option. Pharmacological 
treatment includes analgesics and tricyclic antidepressants. Non-pharmacological 
 21
treatments include patient education, aerobic exercise, strength training and cognitive 
behavioural therapy (CBT) (53;58). 
2.2 Living with a lifelong disease: Adjustment and coping 
Living with a chronic rheumatic disease has the potential to induce profound changes 
in people’s lives. The diseases often fluctuate with symptoms varying from day to 
day or over longer periods of time, and the long-term consequences are 
unpredictable. These potentially stressful experiences will naturally evoke emotional 
reactions and may affect the person’s psychological health (5;6;38). Moreover, the 
need for long-term medical treatment combined with a demand for life-style changes 
will challenge a person’s habitual coping strategies. How people cope with disease-
induced stress and adjust to the changes can influence their emotional wellbeing, 
vitality, life satisfaction, global self-esteem, social interactions and overall QoL (6). 
Previously, research focused mainly on why people failed to achieve healthy 
adjustment, while there currently is a greater emphasis on understanding how 
adjustment is promoted (6;59-61). A wide range of educational and psychosocial 
interventions has been designed to enhance individuals’ coping abilities and facilitate 
their adjustment to the illness. 
2.2.1 Stress, psychological distress and adjustment 
‘Stress’ is a widely used term to describe a process in which an individual is exposed 
to a stressor and reacts with a series of stress responses. A stressor may take many 
forms. It may be a demand (e.g. expectations from self or others), an unmet need (e.g. 
personal goal commitments), a symptom (e.g. pain or fatigue) or an event (e.g. 
disease onset or disease impact per se) (62). Responses to stress include biological 
stress responses (e.g. hormonal responses), cognitive assessment of the stressor and 
behavioural responses. The diversity of biological stress responses will not be 
discussed in this thesis.  
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The experience of distress occurs when an individual perceives the stressor as a 
personal threat, which he/she is unable to control or cope with. The concept 
‘psychological distress’ describes “the unique discomforting, emotional state, which 
an individual experiences in response to a specific stressor that results in harm, either 
temporary or permanent” (62). It may be an already encountered harm (e.g. 
functional limitations) or an anticipated threat (e.g. loss of work). Individuals who are 
distressed may verbally or non-verbally express feelings of discomfort, and they may 
experience changes in their emotional status towards depressed mood, de-motivation, 
irritability, aggressiveness and self-depreciation (63).  
In clinical research psychological distress has often been assessed as symptoms of 
anxiety and depressed mood. Several studies have documented a high degree of 
psychological distress in patients with various rheumatic diseases (5;22;34;64-67). 
The prevalence of major depressive symptoms in persons with RA is higher than in 
healthy controls, varying between 13 and 25%, and persons with FMS are reported to 
be even more depressed (68). Persons with RA also exhibit higher levels of anxiety 
compared with a normative sample, and the gap is greater if the RA is combined with 
depression (23;69). These studies show that many of the factors known to be 
associated with the development of psychological disorders in the absence of physical 
illness are also relevant to the development of psychological problems in people 
living with chronic illness (60). Studies of persons with RA have shown that 
psychological distress is not predicted by the disease activity per se (70). In early 
stages of the disease, it is associated with pain level, disease impact on functional 
status and self-care, life events and perceived social support. In later phases, personal 
coping resources appear to become more important predictors of distress (70-72).  
Adjustment refers to the patients' healthy rebalancing to their new circumstances and 
is a process that occurs over time. It begins at the presentation of symptoms and 
continues throughout the course of the illness (6;60). The process includes cognitive, 
emotional and behavioural responses and is influenced by individual coping 
strategies. A considerable number of patients seem able to adjust to illness without 
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experiencing clinically significant psychological problems. Nevertheless, the 
prevalence of psychological distress among persons with rheumatic diseases indicates 
a need for interventions, which are targeted at strengthening individuals' belief in 
their ability to cope with disease-induced stressors, provide opportunities for 
developing appropriate coping strategies and enhance adjustment to the disease. 
2.2.2 Coping with Stress
Coping has to do with the way people manage life conditions that are stressful (73). 
Lazarus and Folkman distinguished between two main coping strategies: problem-
focused coping aimed at changing the situation that causes distress, and emotion-
focused coping aimed at changing the emotions caused by the stressful event (73;74). 
Two other widely used distinctions differentiate between approach-oriented and 
avoidance-oriented coping, or between passive and active coping strategies (75). All 
three dimensions have been used when studying adjustment to chronic illness, and 
there is no consensus among researchers about which distinction should be preferred 
in studies (76). Empirical evidence has shown that problem-focused or approach-
oriented strategies are most applicable in situations that can be controlled, whereas 
situations beyond control are better dealt with in an emotion-focused approach 
(76;77). Studies in patients with RA has shown that depressed patients are more 
likely to use avoidance-oriented and passive coping strategies (78;79), and that the 
use of such strategies is a mediator of physical disability, pain and depression (80;81) 
and predicts poorer adjustment over time (59). 
Previously, researchers studying stress and coping seemed to agree that emotion-
focused coping processes were passive and avoidance-oriented, and associated with 
maladaptive health-related outcomes (6;82;83). It has more recently been documented 
that a broad coping repertoire, consisting of both problem-focused and emotion-
focused strategies, increases the possibility of matching the response to the particular 
demands of a stressful situation, and therefore may be considered indicators of 
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effective coping (73;76). Based on newer understanding, emotion-focused coping 
strategies are no longer considered as only passive or avoidance-oriented (73;82;83). 
2.2.3 Self-efficacy 
The concept of self-efficacy has its origin in social cognitive theory and is defined as 
an individual’s personal confidence or belief about his or her ability and capacity to 
undertake behaviours that will lead to desired outcomes (84-86). It has to do with the 
power people believe they have to make things happen and consequently their 
perceptions of control (84). The degree of perceived efficacy involves three separate, 
but interrelated conceptual domains: a) having tacit task knowledge and skills, b) 
having an explicit sense of confidence in one’s ability to mobilize the motivation and 
cognitive resources required to perform a skill, and c) having confidence in one’s 
ability to successfully execute a specific task or skill in a given context (86). Self-
efficacy believes are behaviour-specific and a person’s level of self-efficacy may 
therefore differ for various behaviours. Perceived self-efficacy can influence a 
person's motivation and attitude regarding behavioural change, emotions and coping 
attempts (5;86-88). The American nurse and researcher, Kate Lorig, had through her 
studies of patient education, observed that although knowledge might be necessary, it 
is not sufficient for changing behaviour. She was the first to apply the concept of self-
efficacy in the context of rheumatology, showing that without the confidence to 
actually perform a needed activity, one will not achieve the desired outcome (85). 
Thus, self-efficacy is considered an essential component of individuals’ management 
of their disease. Self-efficacy beliefs are found to be modifiable, and the concept is 
frequently used as an outcome measure in psychological and self-management 
interventions (85;86;88;89). Brekke and colleagues have documented associations 
between high self-efficacy and favourable changes in health status in a Norwegian 
cohort of RA patients (90). 
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2.2.4 Emotions and emotion regulation 
There has been an increasing recognition of the role of emotions in adjustment to 
chronic illness. Persons living with chronic rheumatic diseases have to adjust 
emotionally to the consequences of the disease, and the way they regulate their 
emotions may affect their psychological wellbeing as well as other aspects of 
perceived health (6;82;83). Emotions arise when something important to us is at stake 
and call forth “a coordinated set of behavioural, affective and physiological response 
tendencies that together influence how we respond to perceived challenges and 
opportunities” (91). Although emotions trigger ways we respond to a situation, they 
do not force us to respond in certain ways. Emotional responses may be modulated 
and regulated in various ways. Emotion regulation refers to the conscious or 
unconscious processes by which individuals influence which emotions they have, 
when they have them and how they experience and express their emotions (91-93). 
Gross (91) distinguishes between two emotion regulation strategies, antecedent-
focused strategies, i.e. things we do before the emotional response tendencies have 
become fully activated and response-focused strategies, i.e. things we do after 
response tendencies have been generated. How emotions are experienced and 
expressed may have important implications for adjustment to illness. Van 
Middendorp and colleagues (94) describe four styles of emotion regulation: 1) 
Ambiguity, which is difficulty in identifying and describing emotions and 
ambivalence of expressing emotions, 2) Control, which is more or less intentionally 
keeping feelings inside, trying to restrain feelings and be rational when emotions are 
experienced, 3) Orientation, which is being emotionally oriented and experiencing 
emotions intensely, and 4) Expression of negative and positive emotions towards 
others. 
There is a growing consensus that emotion regulation in terms of acknowledging and 
expressing emotions associated with chronic illness can promote healthy adjustment. 
Experimental studies in persons with RA and other chronic pain conditions has 
demonstrated beneficial effects on global disease activity and psychological 
 26 
functioning of emotional disclosure interventions, i.e. talking or writing about 
emotions in stressful experiences (95-99). 
2.2.4.1 Coping through emotional approach: Active processing and 
expression of emotions 
Based on the concepts from stress and coping theory (74), Stanton and colleagues 
demonstrated that there is a type of emotion-focused coping that appears to be 
adaptive rather than maladaptive (83;100;101). They suggested that the reason for the 
erroneous conclusion that emotion-focused coping is associated with maladaptive 
outcomes and psychological distress, is the way it has been operationalised in earlier 
coping measures. Diverse coping strategies, such as approach-oriented (for example 
“I learn to live with it”) as well as avoidance-oriented (for example “I say to myself 
that this isn’t real”) have been assessed as emotion-focused coping. Moreover, 
emotion-focused coping-scales have included both items related to acknowledgement 
of emotions (for example “”I let my feelings out”) and items related to emotional 
distress (for example “I blame myself for becoming too emotional”). Some of these 
items are inversely correlated. Consequently, the scales are not purely assessing 
psychological adjustment, but are mixed with aspects of psychological distress 
(83;100;101). In contrast, Stanton and colleagues argue that the ability to approach 
own and others' emotions is crucial to healthy intra- and interpersonal functioning, 
and they have developed a construct labelled Coping through emotional approach, 
intending to measure the adaptive functions of identifying, acknowledging and 
expressing emotions (101). They developed and validated a new instrument, the 
Emotional Approach Coping Scale (EAC), comprising two distinct factors: 
Emotional Processing, which includes active attempts to acknowledge, explore 
meanings and come to an understanding of one’s emotions; and Emotional
Expression, which includes active verbal and/or nonverbal attempts to communicate 
or symbolise one’s emotional experience. These two factors were found to be related 
to other approach-oriented coping strategies, but uncorrelated with avoidance-
oriented strategies. The EAC has been validated and used in a wide range of 
populations, including breast cancer and chronic pain patients (102-106). 
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Stanton and colleagues have suggested some working mechanisms of emotional 
processing and expression that contributes to the beneficial health effects: 
Acknowledging and seeking to understand emotions may clarify situations and call 
one’s attention to important goals. Emotional processing may promote reappraisal of 
stressors, reduce perceived threat, and help individuals to find benefit in their 
experiences, which in turn may promote positive adjustment. Emotional expression 
may promote habituation to the stressor and aid in regulating individuals' social 
environment by providing information to others about their concerns and thereby 
affecting their responses (101). 
2.2.5 Interventions designed to enhance adjustment and coping 
The change towards a more collaborative approach between health care professionals 
and persons with rheumatic diseases is reflected in the design of interventions aimed 
at enhancing adjustment and coping. There has been a shift away from a primarily 
didactic education, providing the patients with knowledge to comply with prescribed 
treatment, towards a more participatory education aimed at empowering patients with 
skills and knowledge to manage their illness (1-4). Health care professionals are no 
longer the only experts; the patients have their own knowledge that health care 
professionals should understand in order to facilitate individuals’ adjustment to their 
condition (1). The interventions are often referred to as psycho-educational or 
psychosocial, and they include, to various degrees, training of cognitive, emotional 
and behavioural coping skills.  
Although there is some overlap between the various interventions, they also differ 
with regard to theoretical foundations, specific aims and methods. In the following I 
will describe the groups of interventions that are most commonly applied in persons 
with rheumatic diseases. The main results from selected evaluations of these 
interventions are summarised in table 1. 
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2.2.5.1 Self-management interventions 
Self-management is defined as “the individual's ability to manage symptoms, 
treatment, physical and psychosocial consequences and life style changes inherent in 
living with a chronic condition” (107). The main aim of self-management programs 
(SMP) has been to involve patients in the management of their care in order to 
improve their ability to maintain physical function and to cope with the psychological 
demands of living with a chronic illness (89;107;108). The Arthritis Self-
Management Program (ASMP), which was developed by Kate Lorig and colleagues 
at Stanford University, California, US from the 1980s, has become widely spread in 
North America, Europe and Australia. Although they may vary in content, enhancing 
self-efficacy by teaching skills, such as problem solving, goal setting, reinterpretation 
of symptoms, role modelling and mastery experiences are incorporated in most of the 
programs (86;109). In Norway, the ASMP has been adjusted to several chronic 
conditions and is known by the name “To live a healthier life” (“Å leve et friskere 
liv”, www.funkis.no) (110). 
The effects of the SMPs have been evaluated in several controlled trials and the 
results are summarised in a number of reviews (89;107;109;111). A range of 
beneficial short-term outcomes are documented, such as improvements in pain and 
fatigue, disability and psychological health, especially if a behavioural component is 
included (111-113) (Table 1). Lorig et al (114) have also showed that both baseline 
self-efficacy and changes in self-efficacy are associated with future health status. 
However, most outcome effects are generally found to be small, and there is a gap 
between short-term and long-term effects (88;115-117) (Table 1). A proposed 
explanation for this gap is that patients find self-management strategies burdensome 
and difficult to integrate into their lives and that they do not always experience 
immediate benefits in terms of symptom improvement (6). 
2.2.5.2 Cognitive-behavioural interventions 
Cognitive behavioural therapy (CBT) includes a range of strategies aiming to 
facilitate a realistic, but optimistic attitude towards illness and/or more adaptive 
 29
strategies to cope with symptoms (60). CBT is based on the notion that behavioural 
and emotional responses are strongly moderated and influenced by cognitions and the 
perception of events. As the name indicates, the interventions focus on cognitive 
processes although they are not limited to modification of thoughts. Hofmann and 
Asmundson (118) have categorised CBT techniques as primarily antecedent-focused
emotion regulation strategies, i.e. they encourage cognitive reappraisal of emotional 
triggers before they occur or before the emotional response has been fully activated 
(91). 
CBT is a problem-solving process that includes clarifying the status of the presenting 
problem, defining a desired goal, and finding the means to reach that goal. Patients 
are considered to be experts on their own problems. The therapist role is to work with 
the patient to find adaptive solutions to resolvable problems by identifying negative 
automatic thoughts and dysfunctional or irrational beliefs. These thoughts and beliefs 
are treated as hypotheses, which the patients are encouraged to challenge by putting 
themselves in the role of observers rather than being victims of their concerns. By 
confronting themselves with stimuli that provoke negative emotions, they have the 
opportunity to test the validity of their assumptions (118).  
Group interventions based on CBT are often multi-modal. In addition to the cognitive 
strategies, education about the illness, goal setting and activity pacing, relaxation 
strategies, communication skills and management of flare-ups are included (60). 
Some studies on CBT in patients with rheumatic diseases have documented 
favourable effects in psychological health as well as coping and fatigue, especially 
when the intervention is given early in the course of the illness and when it is tailored 
to patients with a psychosocial risk-profile (113;119-123). One study in patients with 
RA and major depression did not find CBT additive to antidepressant medication 
(124) (Table 1). 
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2.2.5.3 Mindfulness and acceptance-based approaches 
More recently some new approaches categorised as mindfulness- and acceptance-
based therapies have received increasing attention (125). One of the core aspects in 
these therapies is training in open-hearted moment-to-moment awareness to internal 
experiences, such as thoughts, feelings and bodily senses without judging or wishing 
things to be otherwise, conceptualised as mindfulness (126). Another aspect of these 
approaches is the cultivation of self-compassion, i.e. kindness and care toward own 
experiences, seeing any thoughts, feelings and sensations that arise as part of the 
human experience rather than a sign of pathology, weaknesses or limitations (125). It 
is believed that experiencing the present moment non-judgementally, openly and 
reflectively can effectively counter the effects of stressors, whereas excessive 
orientation toward the past or the future when dealing with stressors, can be related to 
feelings of depression and anxiety (127;128). Acceptance is perceived to be the 
strongest mediator of human change and development. It is believed that if we can 
observe our thoughts and feelings by friendly accept without responding reflexively, 
we may gradually free ourselves from being controlled by automatic thoughts. In 
contrast to the CBT interventions, mindfulness- and acceptance-based approaches are 
categorised as response-focused emotion regulation, i.e. how we respond to emotions 
after they have been generated (91;118).  
The mindfulness-based interventions have their roots in ancient Buddhist practices of 
meditation and yoga, and have been adapted and described in western secular 
terminology by dr. Jon Kabat-Zinn at Massachusetts General Hospital, Boston, US 
(126). Kabat-Zinn developed a program known as Mindfulness-Based Stress 
Reduction (MBSR), which over time has become widely implemented in western 
countries, including Norway (129-131). The beneficial effects of MBSR on 
depression, anxiety and stress-related symptoms have recently been documented in a 
number of reviews (127;132;133). So far, there are only few studies on mindfulness-
based interventions in persons with rheumatic diseases, but these studies have shown 
significant effects of the MBSR in persons with RA and FMS (134-136) (Table 1). 
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Training of mindfulness-based practice has also been integrated in interventions with 
roots in cognitive behavioural therapy, such as Acceptance and Commitment Therapy 
(ACT) (137) and Mindfulness-Based Cognitive Therapy (MBCT) (138;139). The 
ACT has, in addition to the acceptance and mindfulness strategies, explicit focus on 
enhancing individuals’ ability to live a meaningful and valued life, in which 
unpleasant emotions no longer serve as an obstruction. The aim is to develop larger 
and larger patterns of effective action linked to chosen values in various domains, 
such as family, career and spirituality, referred to as committed action (118;137;140). 
The effects of the ACT has been evaluated in studies of patients with chronic pain 
conditions, and favourable effects have been found in pain, coping and psychological 
health (136;141). To my knowledge there are no published studies of ACT in persons 
with IA. 
The MBCT combines mindfulness-based training with cognitive strategies for 
identifying negative automatic thoughts and dysfunctional or irrational beliefs and 
view thoughts and feelings from a decentred perspective (metacognitive awareness) 
(142). Although trying to change negative thoughts and feelings seems to be contrary 
to the acceptance- and mindfulness-based approaches, there is some evidence that 
integrating mindfulness training into traditional CBT can decrease depressive 
symptoms (138;139). However, to date there are to my knowledge no publications of 
MBCT in persons with rheumatic diseases or chronic pain conditions. 
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2.3 The Vitality Training Program (VTP) 
The name of the intervention, Vitality Training, needs some explanation. The 
Norwegian name is 'Livsstyrketrening', which directly translated means “training of 
life strength”, and covers the purpose and the content of the intervention and the 
process that the participants experience throughout the program. The name was first 
proposed by the anthropologist Hans Einar Hem, who as a participant observer 
evaluated the intervention on behalf of the Norwegian Ministry of Health and Care 
Services in 1997. To find an English concept synonymous to 'livsstyrke', we 
contacted the Department of English Language Studies at the University of Oslo and 
the concept 'vitality' was proposed. Vitality is defined as “(full of) energy and 
enthusiasm” (Oxford Advanced Learner's Dictionary 2005), “capacity to live and 
develop; physical or mental vigour especially when highly developed” (Free 
Merriam-Webster Dictionary), “exuberant physical strength or mental vigour; 
capacity for survival or for the continuation of a meaningful or purposeful existence; 
power to live or grow” (Dictionary.com). These meanings correspond well with the 
intentions behind the Norwegian name 'Livsstyrketrening' and the purpose and 
content of the intervention, and the name 'Vitality Training' was therefore selected. 
The VTP was originally developed for persons with chronic musculoskeletal pain. 
The design of the VTP was driven by the authors' (Eldri Steen and Liv Haugli) 
pragmatic motivation to create a meaningful, feasible and effective intervention and 
by their clinical experience with participation-based teaching and counselling 
methods. The main aim was to develop an intervention that could help people with 
chronic musculoskeletal pain to cope in more constructive ways with their symptoms 
and life challenges (143). Some theoretical assumptions directed the development of 
the programme. 
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2.3.1 Theoretical background and main concepts 
Although Norwegian patients in the 1990s were engaged in promotion of their health 
and to a certain extent involved in decisions regarding their illness, the biomedical 
model was still prevailing in medical care. In this model the body was understood as 
an object and bodily phenomena were considered as symptoms to be diagnosed and 
behaviours to be modified (144). Pain and other symptoms were mainly understood 
as either physical with an identifiable cause, or psychological with unclear or 
unidentifiable causes. Health care professionals were very much the experts who 
owned the knowledge and could decide what was the right and best for any patient 
regardless of his/her preferences. Steen and Haugli proposed a contrasting, 
phenomenological view of the person, in which the human body is considered as a 
subject and carrier of experience and meaning. Thus, bodily phenomena cannot be 
understood as isolated events, but must be viewed in the context of the whole person 
(144). Their main assumptions were: 1) Individuals interpret situations and symptoms 
in multifaceted ways and construct their own meanings of the situations they are in, 
and they have the capacity to reinterpret situations and construct new meanings when 
needed. 2) The impact and meaning of living with a chronic condition can only be 
understood by addressing an individual’s own experience-based knowledge. This 
implies that interventions should provide opportunities for the participants to find 
their own meaningful ways of coping with and adjusting to the disease (143). 
2.3.1.1 Consequences for teaching and learning 
These assumptions resulted in some basic principles for how the intervention should 
be designed (143). The programme should: 
 enhance awareness of the present moment, i.e. pay attention to thoughts, feelings 
and bodily senses as they arise moment-by-moment, without attempting to avoid, 
analyse or judge them 
 enhance awareness of the relationship between inner experiences (senses, 
thoughts, feelings), interpretation of these experiences and behavioural patterns 
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 enhance awareness of personal resources and possibilities rather than symptoms 
and limitations 
 involve cognitive, emotional and behavioural learning processes 
 create learning situations, in which participants are allowed to relate and respond 
actively to any issues and topics addressed 
 facilitate learning as an individual discovery process that cannot be forced 
The theoretical foundation for the learning processes and methods was inspired by 
gestalt psychology and principles of confluent education (145-148). Gestalt 
psychology is concerned with how and what we perceive, and how we construct 
meaning. Fundamental goals are to complete unfinished situations from the past that 
are obstacles to health, wholeness and good contact with oneself and others, and to 
develop the capacity and skills to engage authentically, responsibly and satisfactory 
in the process of everyday living (145). 'Confluent education' is a theory of learning 
derived from gestalt psychology that aims at integrating emotional, cognitive and 
behavioural processes in learning (146-148). Learning is an experience-based process 
that occurs in a dialectic relationship between participant, group facilitator (the 
'teacher'), content and environment. Although developed from different theoretical 
backgrounds, the VTP has many common features with the mindfulness- and 
acceptance-based approaches described in section 2.2.5.3. An underlying belief in 
interventions derived from these approaches, as well as in the VTP, is that increased 
awareness may enable persons to reduce their automatic behaviour responses and 
strengthen their ability to make more conscious choices about how they respond to 
experiences. 
2.3.1.2 Essential concepts in the VTP 
Awareness is how we get in touch with our experiences and access the world through 
our senses, i.e. what we see, hear, smell, taste and feel. Awareness makes options and 
choices possible, instead of automatic and unconscious reactions. Awareness opens 
up for contact with emotions and unfinished situations that hinder movement and 
growth.  
 37
Here-and-now focus: Now is the time to be aware of and pay attention to what is 
actual moment-by-moment, now is when we experience feelings and make choices, 
and now is the only time we have the power to influence an event, for events happen 
only in the moment. 
The paradoxical nature of change: The VTP is not targeted toward changing the 
individual. Change is desired, but we do not force change to come about by having a 
predefined goal. It is not known what this change will be. Paradoxically, change takes 
place when a person stops trying and accepts what is (146;149). 
These three concepts are analogues to the basic principles of awareness of the present 
moment and the processes of non-judgemental attention to whatever arises, internally 
or externally, that we find in the mindfulness and acceptance-based approaches. In 
addition, the VTP focuses on the content of what the person becomes aware of. The 
participant’s experiences, thoughts, feelings and physical reactions are gateways to 
discovering, making explicit, and facilitating the learning processes. The focus is 
always on what the person becomes aware of in the present moment. However, 
feelings and sensations here and now may have their sources in unfinished situations 
from the past, and uncompleted experiences make it difficult to be present now 
because we are partly in the past. Until these feelings are recognised and understood 
they may be obstacles to further growth and development. In the VTP, various 
creative methods, such as guided imagery, movement to music, using crayons and 
white papers to express internal images, poetry and metaphors, are used in 
combination with awareness exercises. The purpose of these methods is to provide 
opportunities for the participants to express thoughts and emotions non-verbally and 
verbally, complete unfinished situations and discover more of whom they are and 
what they need. 
Furthermore, contact is an essential element, i.e. the meeting of myself and what is 
different from myself - other people and things in the environment. Contact assumes 
acknowledgement of own and others' existences as separate beings. Through contact, 
people grow and change. This is never a purely cognitive process, but can include 
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awareness and acknowledgement of our inner experience, such as feelings associated 
with the contact. Contact provides the possibility for relationship with others and the 
potential for process, energy, dialog, and new meanings (145).  
Finally, the VTP is targeted at increasing attention of what is important to the 
individual and strengthen his/her ability to make choices in accordance with their 
own values instead of expectations from others or what they think is socially 
acceptable. This process is analogous to the values-based action described in the ACT 
(137). 
2.3.1.3 Consequences for education of group facilitators 
The group facilitators' own inner and outer awareness is essential. They have to 
possess the skills of being present, paying attention, seeing and hearing the 
participants as they present themselves, and to respond to them human-to-human 
(8;145). They are therefore trained in confluent methods and delivery of the VTP 
before they are approved as group facilitators. The training comprises six three-day 
workshops over one year, plus home assignments and a practical examination at the 
end of the training. Activity, participation, discoveries and reflection on own 
experiences are central elements in the training. By practicing and getting feed-back 
they experience the different methods both as group participants and as facilitators, 
including the importance of respect, trust and acceptance (8). 
The group facilitators are health care professionals, such as nurses, occupational 
therapists, physiotherapists and social workers, who by their professional education 
typically are trained to be ‘experts’ and give advices. In contrast, through confluent 
education they learn not to present the ‘right answers’, but to help individuals explore 
and discover their personal resources and values and to find their own meaningful 
solutions (150). 
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2.3.2 Effects of the VTP in persons with chronic musculoskeletal 
pain
Haugli and Steen evaluated VTP effects in a randomised controlled trial (RCT) for 
persons with chronic musculoskeletal pain, such as fibromyalgia, neck and shoulder 
syndromes and low back pain, (9-11). They found significantly reduced 
psychological distress in the VTP group compared to the controls after the 
intervention and at one-year follow-up (p < 0.001). The differences between groups 
were slightly reduced at one year follow-up, but still significant (p < 0.05) (11). The 
VTP group also reported significantly reduced pain (p = 0.02) and increased pain 
coping and self-care ability compared to the controls at one-year follow-up (p - 
values 0.010 and 0.02, respectively) (10). Persons with high ‘agency-orientation’, i.e. 
those who tends to perceive themselves as originators of behaviours, benefited more 
from the program in terms of higher coping ability and self-care ability than persons 
with low ‘agency-orientation’ (p - values < 0.05) (9). The authors also conducted a 
qualitative study, using open-ended questions in self-report questionnaires 
immediately after and one year after the intervention. Analyses of participants’ 
written texts showed that they had gained increased awareness of the complex 
relations between their bodily symptoms, thoughts, feelings and their current life 
situation. They had also increased their awareness of own resources and possibilities 
as opposed to focusing on diagnoses. The VTP had provided a room for 
experimenting, for experiencing community and for acceptance of self and others. 
The group facilitators’ abilities to act as human-to-human and to focus on self-
discovery rather than symptoms, had been important (8). 
2.3.3 The rationale for the present study 
Based on the described needs for interventions that enhance adjustment and coping 
resources in persons with chronic rheumatic diseases and the lack of such 
interventions in the Norwegian rheumatology context, we searched for appropriate 
interventions. The VTP had showed beneficial effects on psychological distress and 
pain in persons with chronic musculoskeletal pain. Persons with inflammatory 
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rheumatic diseases frequently report these symptoms as well. Additionally, the VTP 
explicitly addresses emotional responses to chronic conditions and the relations 
between thoughts, feelings and bodily symptoms in a way we did not find in existing 
interventions. Moreover, the VTP had integrated the recognition of patient 
perspectives of their condition and taken seriously that persons with chronic 
conditions have their own knowledge and ability to create meanings in their 
situations. Finally, the training of awareness (mindfulness) in combination with 
creative methods and focus on resources and possibilities rather than strategies to 
reduce symptoms, is an innovative approach that has previously not been investigated 
in persons with chronic rheumatic diseases. 
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3. Aims of the study 
The main aims of this research project were 1) to evaluate the clinical effects of the 
VTP in patients with chronic rheumatic diseases, 2) to explore participant experiences 
of the VTP, and 3) to test the measurement properties of the Emotional Approach 
Coping Scale (EAC), in Norwegian patients with rheumatic diseases. 
The specific research questions were: 
 Can VTP participation improve psychological wellbeing, self-efficacy and 
disease-related symptoms in persons with inflammatory rheumatic diseases and 
fibromyalgia? (paper I)  
 Which factors predict reduction in psychological distress? (paper I) 
 How do persons with rheumatic diseases experience VTP participation in terms of 
influence on their emotional wellbeing and coping behaviour? (paper II) 
 By which processes do these influences arise? (paper II) 
 Is EAC a valid instrument in Norwegian persons with rheumatic diseases? (paper 
III) 
 Is EAC responsive to change in Norwegian persons with rheumatic diseases? 
(paper III) 
 What are the effects of the VTP on psychological wellbeing, self-efficacy and 
emotion-focused coping, compared to routine care plus a CD with mindfulness-
based home exercises, in persons with inflammatory rheumatic joint diseases? 
(paper IV) 
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4. Materials and methods 
4.1 Methodological considerations 
There is increasing understanding that both qualitative and quantitative methods are 
useful when studying complex interventions (151;152). The two methods generate 
different kind of knowledge that in combination contribute to a broader and more 
profound understanding of the mechanisms of the interventions (153). For this reason 
we used both quantitative and qualitative methods in the present research project. The 
quantitative methods allowed quantification of effects by studying associations 
between the variables, predictions and by comparing groups. The qualitative methods 
allowed more extensive descriptions of how the intervention worked according to 
participant experiences. We assumed that the data we obtained by using different 
methods would complement each other. 
4.2 Study designs 
Paper I was a longitudinal pre – post-test study with a one-year follow-up. Paper II 
was as a qualitative focus group study. The study of measurement properties of the 
EAC, reported in paper III, included both a cross-sectional design (validity) and a pre 
– post-test design (responsiveness). Paper IV was an RCT, in which participants were 
allocated to either VTP or a routine care control group that received a CD with 
mindfulness-based home exercises for individual voluntary use. 
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Figure 1: Overview of the project 
4.3 The intervention 
The VTP comprised ten group sessions over a 15 weeks period plus a booster session 
after approximately six months. Each session lasted for 4.5 hours and addressed a 
specific topic related to living with chronic illness (Table 2). The number of 
participants in each VTP group ranged from eight to twelve. Through various 
awareness exercises participants were encouraged to become aware of, and 
intentionally attend to, their emotions, thoughts and bodily senses without attempting 
to change or avoid them (mindfulness). In addition, creative exercises, such as guided 
imagery, music, drawing, poetry and metaphors were used to encourage active 
participation and provide opportunities for experiences and discoveries (see section 
2.3.1.2). Reflections on own experiences were promoted through writing, sharing and 
listening to one another within the group. Between sessions participants performed 
awareness and relaxation training by listening to a CD with mindfulness-based 
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exercises, and they wrote reflective diaries (8). The group facilitators were 
responsible for allowing participants to choose if, and to what extent they would take 
part and engage in the different exercises and how much they wanted to share with 
others. 
 
Table 2: Topics addressed in each group session 
Session 1 Getting to know each other, presentation of group values  
“If my body could talk …..” 
Session 2 “Who am I?” My personal resources 
Session 3 “Who am I in relation to others?” 
Session 4 Values: “What is important for me now?”  
Session 5 What do I need? Knowing one's strengths and limitations  
Session 6 Anger 
Session 7 Joy 
Session 8 Sorrow  
Session 9 Individual resources, possibilities and choices 
Session 10 Anchoring of discoveries and the way ahead 
 
The following is an example from group session 6: Anger 
The first part of the programme is common in all sessions: Participants are invited to 
share their reflections on experiences from home exercises after the previous session 
in groups of three to four persons. They are encouraged to read their reflective diaries 
for each other and to share and listen with an open, non-judgmental attitude without 
discussing or giving advice. Next, participants are invited to take part in an awareness 
exercise instructed by one of the group facilitators. They are guided to attend to their 
thoughts, feelings and bodily senses in the present moment with openness, acceptance 
and curiosity. After the exercise, they are invited to share their experiences with one 
other person in the group.  
In the next part of the session, the group facilitators introduce the topic 'anger' by 
giving a short introduction about the relationship between chronic illness and 
emotions and the purpose of addressing emotions. The participants are then invited to 
take part in an exercise with awareness of anger, instructed by one of the facilitators: 
“Think of the word anger... or to be angry. Notice what you become aware of... 
thoughts, maybe concrete situations, perhaps memories from the past... Are the 
situations that you become aware of new or old? Maybe both?.... What do you 
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experience in your body right now when you think of anger or being angry?... Also 
note whether the word anger or being angry evokes any other feelings...” 
Awareness of anger is continued in movement to music. The music allows 
participants to express anger with their body and they are invited to let their bodies do 
what they want to do while listening to the music. Then, written hypothetical 
sentences are used to enhance discovery of tacit knowledge, for example: “If there are 
any other emotions related to my feeling of anger, it must be...” Participants are 
further invited to share and reflect upon experiences and discoveries from the 
exercises in small groups and in a plenary session. 
The next exercise is a guided imagery intending to help individuals to connect to their 
experiences of anger in the present moment, and to explore its meaning. Further, 
crayons and white papers are used to draw an image of anger as experienced here and 
now. Again, participants are invited to share and reflect in small groups and in 
plenary, with a focus on new discoveries and the consequences of these discoveries 
for the participants' daily life. Finally, they write a diary about their experiences from 
the whole session. 
Before closing the session, participants are asked to be aware of how they relate both 
to their own anger and anger from others in their daily lives, and to listen to one track 
on the CD every day. They are also asked to write reflective diaries about their 
thoughts, emotions and bodily senses. The session ends with a relaxation exercise. 
Each session follows the same structure with exercises adapted to the particular topic. 
4.4 Study participants 
The study included participants from three different samples: 1] Patients who 
participated in the VTP in 2003 and 2004 (papers I and II). 2] Patients recruited for 
the purpose of testing the measurement properties of the EAC (paper III). 3] Patients 
included in the RCT 2007 - 2009 (paper IV). 
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4.4.1 The pre – post-test and focus group studies (papers I and II) 
Persons with various rheumatic diseases were recruited from six rheumatology 
departments in southern Norway. Inclusion criteria were confirmed rheumatologic 
diagnosis, age 20 years or older and good understanding of Norwegian language. 
Health professionals at the rheumatology outpatient clinics and the rheumatology in-
patient wards at the hospitals informed patients about the VTP courses, gave them 
information leaflets and invited them to attend open information meetings. Those 
who were interested after the information meetings enrolled in the VTP. If they also 
met the inclusion criteria they were asked to participate in the study. 
A total of 213 patients took part in the open information meetings, 181 enrolled in the 
VTP and 175 agreed to study participation (Figure 2). Included patients had the 
following diagnoses: RA (n = 63), FMS (n = 63), PsA (n = 12), AS (n = 8), OA (n = 
8), systemic lupus erythematosus (SLE) (n = 8), JIA (n = 2), Still's disease (n = 1), 
polyarthritis (n = 1) and other rheumatologic diagnosis (n = 9). One of the 
departments invited only patients with FMS to participate, because they considered 
the VTP to be a relevant treatment option for this group of patients to whom they had 
no other good treatments.  
Three patients dropped out after only one session and were excluded from the study, 
resulting in 172 patients who completed the VTP. Twenty VTP groups were 
conducted between January 2003 and November 2004. Participants in the first 10 
courses (n = 91), representing five of the rheumatology departments, were asked to 
take part in focus group interviews two weeks after they had completed the VTP, and 
a total of 69 patients agreed to participate in the interviews (Figure 2). 
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Figure 2: Flow chart of participants included in papers I and II
 
4.4.2 The study of measurement properties of the Emotional 
Approach Coping Scale (paper III) 
Three patient groups were recruited in 2007. For the cross-sectional validation study 
118 consecutive patients (group 1) who attended regular consultations at 
rheumatology inpatient wards, outpatient or day clinics at four different 
rheumatology departments were recruited. In addition, 49 patients (group 2) attending 
four VTP courses and 103 patients (group 3) attending five diagnosis-specific SMP 
courses were recruited for the pre – post-test study of responsiveness. All data from 
group 1 and baseline data from group 2 and 3 were used in the cross-sectional study 
(Figure 3). 
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Inclusion criteria were adults with confirmed rheumatologic diagnosis in the 
consecutive sample (group 1) and confirmed rheumatologic diagnosis of at least six 
months duration and age over 20 years in the two VTP- and SMP courses (group 2 
and 3). 
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Figure 3: Participants included in paper III
 
4.4.3 The randomised controlled trial (paper IV) 
Participants were recruited from three rheumatology departments in south-eastern 
Norway between March 2007 and June 2009. Inclusion criteria were inflammatory 
rheumatic joint disease diagnosed at least one year earlier and age between 20 and 70 
years. Non-inflammatory diagnosis and inability to understand Norwegian language 
were exclusion criteria. 
A project assistant at each department asked patients who regularly visited their 
clinics to participate. In addition, participants were recruited from random samples 
drawn from two registers at Diakonhjemmet Hospital in Oslo of patients fulfilling the 
ACR 1987 criteria for RA (154) and the New York classification criteria for AS (15). 
All interested participants attended information meetings chaired by the project 
assistants.  
From a total of 814 invited persons, 113 attended the information meetings. Seventy-
three persons were willing to participate in the study and were randomised: 37 to 
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VTP and 36 to the control group. Sixty-eight persons completed the assessments 
post-treatment (34 in each group), and 67 completed the 12-month assessments (34 in 
VTP and 33 in control). 
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Figure 4: Flow chart of participants in paper IV
 
4.5 Data collection 
4.5.1 Quantitative evaluation of the VTP (papers I and IV) 
In the pre – post - VTP evaluation data were collected through comprehensive self-
report questionnaires before the intervention (baseline), immediately after the 
intervention and 12 months after completion of the intervention. Questionnaires were 
given to the participants by the group facilitators before the first and after the last 
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VTP-session. The one-year follow-up questionnaires were sent to participants with a 
postage-paid return envelope. 
Participants in the RCT were assessed by a comprehensive self-report questionnaire 
at baseline, post-intervention and 12 months from baseline. The 12-month follow-up 
was accelerated compared to the pre – post-test study, so that the control group 
should not have to wait too long for possible VTP participation. All questionnaires 
were sent to participants with a postage-paid return envelope.  
There is a considerable day-to-day variation in self-reported symptoms in patients 
with inflammatory rheumatic joint diseases (155). Thus, in order to reduce between-
person variation, selected outcomes (pain, fatigue, wellbeing, self-care ability and 
self-reported disease activity, see section 4.6 and Table 4) were measured by 
telephone interviews four times at two-week intervals at baseline, post-intervention 
and at 12-month follow-up in addition to being included in the questionnaires. This 
gives a total of five measurements at each assessment point. By the repeated 
measurements, we assumed to get a more reliable value of these measures. The 
participants had the questionnaires in front of them during the telephone interviews. 
4.5.2 Qualitative evaluation of the VTP (paper II) 
Qualitative data were obtained from focus group interviews approximately two weeks 
after the VTP. Three different experienced interviewers, all with good knowledge of 
the VTP, but who had not facilitated any of the groups, moderated the interviews. A 
semi-structured interview guide was used as a checklist (Table 3). The interviewers 
aimed at being responsive to any issues as they arose within the group and creating an 
open conversation, in which all participant views could be comprehensively explored, 
particularly divergent experiences and critical issues. The interviews lasted 1 - 1.5 
hours, were audio taped and transcribed verbatim. No names were used in the 
interviews, and all data were de-identified to ensure confidentiality. The group 
facilitators did not take part in the interviews.  
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Table 3: Semi-structured interview guide
How did you experience to be part of the VTP? 
Have any of the topics been especially important to you? 
Do you think any topics should have been excluded? 
Have you had any negative experiences from participating in the VTP? 
Has participation in the VTP in any way been of importance to your daily life? 
How did you experience relating to the different topics in a group context? 
How was your relationship to the other group participants? 
Has it in any way been important for you to listen to the CD with different exercises? 
How did you experience the various methods used in the VTP? 
Have the group facilitators in any way been important to you? 
What do you thing about the way the group was organised?  
Is there anything else you want to say?  
 
4.5.3 Evaluation of measurement properties of the Emotional 
Approach  Coping Scale (paper III) 
For the cross-sectional study self-report questionnaires were given to patients at a 
single data collection point. The patients who were consecutively included from the 
rheumatology departments (group 1), got the questionnaires from a rheumatology 
nurse and were given the choice of filling it out in the waiting-time at the clinic or 
bringing it home and return it in a postage-paid return envelope. Participants in the 
VTP (group 2) got the questionnaires from the group facilitators immediately before 
the first VTP-session, and questionnaires were sent with a postage-paid return 
envelope after the last session. Participants in the one-week SMP (group 3) were 
given the questionnaires by a nurse at the beginning of the first day and at the end of 
the last day of the course. All questionnaires were marked with an id-number and 
returned anonymously to the project leader for plotting and analyses. 
4.6 Measures in the studies 
All measures were self-reported, except for age, diagnoses, and disease duration, 
which were obtained from the patients’ records. The measures are listed in Table 4. 
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4.6.1 Demographic and disease variables 
Age, gender, marital status, work status, rheumatologic diagnosis, disease duration 
(i.e. time since diagnosis) and duration of symptoms were included in all papers. 
Additionally, education, use of medication and co-morbidity were included in paper 
IV. 
4.6.2 Physical function 
Physical function was measured by the Stanford Health Assessment Questionnaire 
(HAQ) (156) in paper I and by the Stanford Modified Health Assessment 
Questionnaire (MHAQ) (157;158) in paper IV. HAQ covers eight activity 
performance categories, such as dressing, rising, eating, walking, hygiene, reaching, 
gripping and daily activities. In MHAQ these items are collapsed to eight activities of 
daily living. Both instruments are scored on a scale ranging from 0 (without 
difficulty) to 3 (unable to do). In paper IV self-reported physical activity was 
included as an ordinal variable with the answering categories “no activity”, “0.5 - 1 
hour/week”, “1 - 2 hours/week”, “3 - 4 hours/week”, and “more than 5 hours/week” 
and then dichotomised into “less than 2 hours/week” and “more than 2 hours/week”. 
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Table 4: Overview of measures included in papers I – IV 
Demographic and disease 
variables Included in paper 
Age (years) I, II, III, IV 
Gender (male/female) I, II, III, IV 
Marital status (living with/without 
partner) I, II, III, IV 
Education (less/more than 12 
years) IV 
Employment (paid work: yes/no) I, II, III, IV 
Diagnosis I, II, III, IV 
Disease duration (years since 
diagnosis) I, II, III, IV 
Symptoms duration (years) I, II, IV 
Medication (type) IV 
Co-morbidity (yes/no) 
 
IV 
Physical function Item scoring Included in paper 
Health Assessment Questionnaire 
(HAQ) 0 – 3, 0 = without difficulty I 
Modified Health Assessment 
Questionnaire (MHAQ) 0 – 3, 0 = without difficulty IV 
Physical Activity  </= 2 hours/week / > 2 hours/week IV 
Psychological wellbeing   
General Health Questionnaire-20 
(GHQ-20) 0 – 3, 0 = no distress I, III, IV 
Wellbeing (VAS/NRS) 0-100, 0 = very well/  0-10, 10 = very well I / IV 
Coping   
Arthritis Self-Efficacy pain Scale 
(ASES pain) 10 – 100, 100 = totally confident I, IV 
Arthritis Self-Efficacy symptoms 
Scale (ASES symptoms) 10 – 100, 100 = totally confident I, IV 
Emotional Approach Coping 
Scale (EAC) 
1 – 4, 4 = high processing/ 
expression of emotions I, III, IV 
Self-care ability (VAS/NRS) 0-100, 0 = very good/  0-10, 10 = very good I / IV 
Brief Approach/Avoidance 
Coping Questionnaire (BACQ) 
1 – 4, 4 = high approach-oriented 
coping III 
Disease-related symptoms   
Pain (VAS/NRS) 0-100/0-10, 0 = no pain I / IV 
Fatigue (VAS/NRS) 0-100/0-10, 0 = no fatigue I / IV 
Patient Global disease Activity 
(PGA), (VAS/NRS) 0-100/0-10, 0 = no activity I /IV 
VAS = Visual Analogue Scale, NRS = Numerical Rating Scale 
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4.6.3 Psychological health and wellbeing 
4.6.3.1 Psychological distress 
Psychological distress was assessed by the General Health Questionnaire, 20-item 
version (GHQ-20) (159;160). The GHQ-20 measures several aspects of 
psychological health during the previous two weeks and is balanced between 
positively phrased items, indicating psychological health, and negatively phrased 
items, indicating psychological distress. In studies measuring change, scoring on a 
four point Likert scale (0 to 3) is recommended (159;161). This gives a possible sum 
score of between 0 (no distress at all) and 60 (much more distress than usual). The 
GHQ is a widely used screening instrument for psychological distress and is also 
found to be sensitive to changes in distress over time (160;162). A suggested 
threshold for serious psychological distress is a sum score above 23 (161;163). The 
GHQ-20 has been validated and used in various samples of chronically ill persons in 
Norway (161;163;164). The GHQ-20 was the primary outcome measure in paper I 
and IV, and was used for measuring construct validity in paper III. 
4.6.3.2 Overall wellbeing 
In paper I, patient perceptions of overall wellbeing was assessed by a 100 mm Visual 
Analogue Scale (VAS) with the question “How are you now?” The scale was 
anchored by 0 (very well) and 100 (very bad). In paper IV, the same question was 
assessed by a Numerical Rating Scale (NRS) and reversed, thus scored from 0 (very 
bad) to 10 (very good). The reason for the change of scales from VAS to NRS was 
that the measures were used in telephone interviews, in which it was necessary to 
answer by an exact number. 
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4.6.4 Coping measures 
4.6.4.1 Self-efficacy 
Self-efficacy is the confidence that one is capable of achieving a specific behaviour 
or a cognitive state (84;88;165) and is assumed to facilitate behaviour change that can 
alter health outcomes (86;109). Self-efficacy was assessed in paper I and IV by two 
subscales of the Arthritis Self-Efficacy Scale (85), self-efficacy pain (5 items) and 
self-efficacy symptoms (6 items). Each item is scored from 10 (not at all confident) to 
100 (totally confident). For each subscale scores are summed across the items and 
divided by the number of items. A Norwegian translation has been used in previous 
prospective studies in RA patients (90;166). 
4.6.4.2 Emotion-focused coping 
Emotion-focused coping was assessed by the Emotional Approach Coping scale 
(EAC) that measures ability to acknowledge, understand, and express emotions (101). 
The EAC comprises 16 items that form two subscales: emotional processing (eight 
items), for example “I realise that my feelings are valid and important” and emotional 
expression (eight items), for example “I allow myself to express my emotions”. Each 
item is scored from 1 (not at all) to 4 (in high degree). The mean item score is 
calculated for each subscale. The Norwegian translation of the EAC was validated in 
paper III. 
4.6.4.3 Approach/avoidance coping 
The Brief Approach/Avoidance Coping Questionnaire (BACQ) was used to measure 
construct validity of the EAC in paper III. The BACQ comprises 12 items designed to 
measure a general concept of approach-oriented versus avoidance-oriented coping. 
Items are scored on a 5-point Likert scale from “strongly disagree” to “strongly 
agree”. Examples of approach-oriented items are: “I say so if I am angry or sad” and 
“I make an active effort to find a solution to my problems”. Examples of avoidance-
oriented items are: “I bury myself in work” and “I try to forget my problems”. The 
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BACQ was found to have satisfactory measurement properties in a Norwegian 
population of primary care patients (75).  
4.6.4.4 Self-care ability 
Patients’ perception of self-care ability was assessed by 100 mm VAS with the 
question “How will you describe your ability to take care of yourself in everyday 
life?” The scale was anchored by 0 (very good) and 100 (very bad) (10). In paper IV, 
the same question was assessed by NRS and reversed, thus scored from 0 (very bad) 
to 10 (very good). 
4.6.5 Symptoms and disease activity 
In paper I, patients’ perceptions of pain and fatigue were measured by 100 mm VAS 
anchored by 0 (no pain/fatigue) and 100 (intolerable pain/fatigue). Patient global 
disease activity (PGA) was assessed by the patient global 100 mm VAS anchored by 
0 (good/no symptoms) and 100 (very bad symptoms). In paper IV, the same 
assessments were performed by NRS, scored from 0 (no pain/fatigue/symptoms) to 
10 (intolerable pain/fatigue/very bad symptoms). 
4.7 Sample size, randomisation and blinding in the 
randomised controlled trial 
4.7.1 Sample size calculation 
The GHQ-20 was selected as a primary outcome measure and used for sample size 
calculation in the RCT. There are no clear recommendations in the literature about 
what a clinically relevant change in the GHQ-20 might be. In the pre – post-test study 
we found a 10% reduction in GHQ-20 in patients with IA at one-year follow-up 
(mean change 6.0, see Main results section 5.1). With a power of 80%, a significance 
level of 0.05 and anticipating that we would find a mean change difference of 5.0 
between the groups in the RCT, we calculated the sample size as 72 participants in 
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each group. To manage the study within a reasonable time frame we would have to 
reduce the sample size, but still keep the power. A previous study in Norwegian RA 
patients has shown that using up to five repeated measurements per patient can 
decrease the between-person standard deviation (SD) and consequently the number of 
patients required in a trial by as much as 20% (167). We therefore conducted a small 
pilot study in which we calculated the individual means for five repeated 
measurements on GHQ-20 at baseline and the follow-up visits. Based on this study 
we hypothesised that the RCT would detect a difference between groups of 4.5 in 
GHQ-20 with an estimated SD of 3.9, and a probability of a slight improvement of 
0.9 in the control group. A bootstrap procedure was performed, and the sample size 
was calculated to 34 in each group. 
4.7.2 Randomisation and blinding 
A statistician generated randomisation lists, using Statistical Analysis Software (SAS) 
version 9.1.3. The randomisation lists were based on blocks of 10 and 15 for each 
department to ensure approximately equal sample sizes. Participants from each 
department were given consecutive numbers and a person not involved in the data 
collection or intervention, allocated each participant to the corresponding number on 
the randomisation list. 
The persons who conducted the telephone interviews were blinded for group 
assignments, and participants were instructed not to discuss their intervention with 
the interviewer. A blinded statistician conducted the primary statistical analyses, and 
the randomisation code was not opened until these analyses were completed. 
4.8 Analyses
Qualitative analyses were carried out manually. For statistical analyses the Statistical 
Package for Social Science, version 14 (IBM SPSS Statistics©) and the Statistical 
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Analysis Software, version 9.2 (SAS Institute Inc©) were used. The level of 
statistical significance was set at  = 0.05 for all analyses. 
4.8.1 Statistical methods and analyses of quantitative data 
Descriptive statistics for baseline values in papers I, III and IV were calculated as 
means and standard deviations (SD) for continuous variables and as percentages for 
categorical variables. If a variable had a skewed distribution, median was calculated 
instead of mean. 
4.8.1.1 Analyses in paper I 
Baseline differences between completers and non-completers of the one-year follow-
up assessments were examined by two-sample independent t-test for continuous 
variables and Pearson’s chi-squares for categorical variables.  
Paired t-tests were used to examine changes in outcome variables from baseline to 
post-intervention and from baseline to one-year follow-up. First, analyses of changes 
were calculated for all participants. Second, the sample was divided into three 
diagnostic groups: the IA-group (i.e. RA, AS, PsA, JIA, Still's disease and 
polyarthritis), the FMS-group and the group of “others” (i.e. OA, SLE, others). The 
latter group was excluded from the further analyses because of its heterogeneity and 
small number. Effect sizes (ES) for the change scores were calculated as standardised 
response means (SRM) by dividing mean change for each outcome measure by the 
SD of the change score (168;169). The values of the SRMs were interpreted 
according to Cohen's effect size index, in which less than 0.20 is considered trivial, 
0.20 – 0.49 is considered a small difference, 0.50 – 0.79 a moderate difference and 
more than 0.80 a large difference (169;170).  
Possible predictors of change in psychological distress from baseline to one-year 
follow-up were explored by bivariate and multivariate regression analyses. Age, 
disease duration, diagnosis (IA and FMS) and the baseline values of ASES pain and 
symptoms, wellbeing, self-care ability, pain, fatigue, PGA and HAQ were chosen as 
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predictor variables and entered into a bivariate regression model with change in 
GHQ-20 from baseline to one-year follow-up as the dependent variable. The 
procedure used for the multivariate regression model was Hosmer’s manually 
backward elimination technique (171). All variables that were significant at the 0.30 
level in the bivariate analyses were included in the initial multivariate model. At each 
step, the least significant variable was removed. This process continued until only 
significant variables remained in the model. All included variables were tested for 
confounding. In the final model interactions and model assumptions were assessed 
using Cook's distance (Cook's d) and Jackknife residuals. Interactions were included 
only if they were significant at the 0.05 level. 
4.8.1.2 Analyses in paper III 
The purpose of the analyses in this paper was to test the Norwegian version of the 
EAC for data quality, internal consistency reliability, construct validity and 
responsiveness to change.  
In order to assess the acceptability of the instrument, levels of missing data were 
assessed for all items. Evidence for the existence of the two EAC subscales was 
assessed by principal component analyses (PCA) with varimax rotation (172). 
Components with eigenvalues greater than one were considered potentially 
important. Internal consistency was assessed by item-total correlations and 
Cronbach’s alpha. For a scale to be sufficiently reliable for use in groups of patients, 
an alpha value of between 0.70 and 0.90 was considered acceptable (173;174). 
Because no ‘gold standard’ for assessing emotional approach coping exists, criterion 
validity was not assessed. 
A construct can be thought of as a “mini-theory” to explain the relationships among 
various behaviours and attitudes. Construct validation is an ongoing process of 
learning more about the construct, making new predictions, and then testing them 
(174). To assess the construct validity of the EAC, we compared the scale with two 
other instruments, the BACQ, which measures approach and avoidance-oriented 
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coping, and the GHQ-20, which measures psychological distress.  Pearson's 
correlation coefficient was used to calculate the correlations between the instruments 
(174;175).  Because the EAC-scales were designed to measure approach-oriented 
coping, we hypothesised that the EAC scores would be positively correlated with the 
approach-oriented items in the BACQ. However, the EAC-scales and the BACQ 
measure different aspects of coping, and hence correlations with the BACQ were 
expected to be low to moderate (0.3 - 0.6). Furthermore, because the EAC-scales 
were intended not to be interfered with distress-related content (101), we expected 
low level (< 0.3) negative correlations with GHQ-20. 
Responsiveness refers to an instrument’s ability to measure change over time 
(174;176;177). This was assessed in the VTP and the SMP samples by paired 
samples t-tests and the magnitude of the changes were compared by the SRMs. 
Because processing and expression of emotions are more explicitly addressed in the 
VTP than in the SMP, and the VTP is of longer duration (15 versus one week), we 
hypothesised that participants in the VTP would have a larger increase in the EAC 
scores compared to participants in the SMP. 
4.8.1.3 Analyses in paper IV 
All outcome variables in this paper were continuous and results were reported as 
mean values with confidence intervals (CI).  
The average mean values of the five repeated measurements, as well as the single 
means of variables measured once at each time point, were used in the analyses. 
Treatment effects (mean differences between the groups post-treatment and at 12 
months) were estimated with mixed models repeated measures analysis. This model 
includes the interaction of treatment and time (i.e. post-treatment and 12 months). We 
adjusted for age, gender, disease duration, education, and marital status, as well as for 
the individual baseline values for each outcome, but none of these were significant in 
any model, and they were therefore removed in the final model. The mixed models 
analysis is robust to missing values because the patients are included at time points 
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with non-missing values only. A parametric bootstrap procedure was applied to 
ascertain the robustness of the findings. The model assumptions were assessed using 
Cook's d and Covratio statistics for individuals as well as for the estimated 
covariance. The treatment effect sizes (Cohen’s d) were calculated as the adjusted 
between-group difference in scores at 12 month follow-up divided by the pooled SD 
of the baseline scores for each variable (178). 
4.8.2 Analyses of qualitative data 
A secretary transcribed all the audio taped focus group interviews verbatim. The data 
were analysed by an inductive content analyses approach. This approach implies 
moving from the specific to the general, so that particular instances are observed and 
then combined into a larger whole or general statement (179;180). Two researchers 
independently read transcripts from each focus group interview several times and 
notes and headings were written in the texts (i.e. open coding). Codes were then 
categorised according to the topics in the interview guide. The two researchers 
compared their analytical codes and categories, differences were negotiated and new 
categories were formed. Transcripts were read again and any themes that were not 
covered by the interview guide were identified. Descriptions of feelings and 
emotional processes were especially looked for, as well as disagreements within 
groups. A third experienced qualitative investigator read abstracts from the 
transcripts, and analyses were discussed with her to ensure that all themes were 
comprehensive and inclusive. Coded themes were compared across the groups in 
order to identify similarities and differences, and then grouped into broader 
categories, using content-characteristic words (180). The categories and selected 
citations from the texts were discussed with a group of co-researchers. Finally, the 
identified categories were grouped according to the aims of the study, as covering 
either types of influences that arouse from the intervention or the processes whereby 
influences arouse. A professional translator translated the quotes that were chosen to 
illustrate the analytic categories into English. 
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4.9 Ethical aspects 
All studies were conducted according to the principles of the Declaration of Helsinki. 
Because the VTP is an intervention, in which the participants are invited to take 
active part in the different exercises and to share their thoughts and emotions, it was 
particularly important to provide thorough information in advance. The study was 
explained in a letter, in which the patients who were interested, were invited to an 
information meeting. In this meeting they got extensive information about the 
intervention and the study before they decided to take part. All participants gave their 
written consent. The Regional Committee for Medical Research Ethics and the Data 
Protection Supervisor (“Personvernombudet ”) at Oslo University Hospital 
(previously Ullevål University Hospital) approved the studies. 
The education program for group facilitators ensured that they were qualified to 
deliver the VTP with appropriate knowledge and skills and to manage the group 
processes and individual reactions that might occur. They were obligated to maintain 
secrecy about all information from the group participants. 
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5. Main results 
5.1 Improvements in persons with inflammatory rheumatic 
diseases and fibromyalgia after participation in the VTP 
(paper I) 
146 (83%) patients answered the questionnaires post intervention and 126 (72%) at 
one-year follow-up. No significant differences were found in baseline scores between 
those who completed questionnaires at one-year follow-up and those who did not. 
When the diagnoses grouped as “others” were excluded, 128 remained post 
intervention (IA = 76, FMS = 52) and 114 (IA = 70, FMS = 44) at one-year follow-
up. Psychological distress, wellbeing, self-efficacy pain and symptoms and self-care 
ability were significantly improved in the IA group after intervention, and the 
improvements were maintained at one-year follow-up (all p-values < 0.001, SRMs 
ranged from 0.63 to 0.41) (Table 5). No significant reduction was found in fatigue 
after intervention, but at one-year follow-up fatigue was significantly reduced in the 
IA group (p = 0.007). There was also a small reduction in pain at one-year follow-up 
(p = 0.03). No statistically significant improvements were found in any variables in 
the FMS group (Table 5). 
The bivariate regression analyses showed that wellbeing, diagnosis and fatigue were 
the main predictors of change in psychological distress. In multivariate regression 
analyses IA diagnosis and higher scores of fatigue at baseline were the main 
predictors of reduction in psychological distress at one-year follow-up, after adjusting 
for all other variables (Table 6). 
From these findings we hypothesised that the VTP can reduce psychological distress 
and improve self-efficacy and wellbeing in patients with IA. There was no support 
for such improvements in patients with FMS. We concluded that a controlled trial 
was needed to further test and possibly confirm these results. 
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Table 5: Baseline scores and mean change from baseline to post-intervention and from baseline to 12-month follow-up 
for patients with inflammatory arthritis (IA) and fibromyalgia syndrome (FMS) 
  
Baseline  
(N=150) 
Mean (SD) 
Post-intervention 
(N=128) 
Mean (95% CI) P-value* 
12 months
(N=114) 
Mean (95% CI) P -value* 
SRM
(12 months) 
Psychological distress (GHQ-20) (0 - 60, 0 = no distress)  
  IA                             23.1 (9.5) -8.2 (5.9 to 10.5) < 0.001 - 6.0 (3.3 to 8.7) < 0.001 0.52 
  FMS 27.4 (11.0) - 4.2 (- 0.2 to 8.6)    0.06 - 0.02 (- 4.5 to 4.5)    0.99 0.00 
Wellbeing (VAS 0 - 10, 0 = very good) 
  IA                             42.1 (24.2) -12.0 (6.8 to 17.2) < 0.001 -13.7 (8.5 to 19.0) < 0.001 0.63 
  FMS 51.6 (21.7) - 6.6 (- 0.7 to 13.8)    0.07 - 5.5 (- 3.0 to 14.0)    0.20 0.02 
Self-efficacy pain (10 - 100, 100 = high) 
  IA                             54.2 (18.7)   6.6 (- 9.6 to -3.6) < 0.001  9.0 (- 13.4 to -4.5) < 0.001 0.48 
  FMS 48.3 (16.3) - 1.0 (- 3.7 to 5.7)    0.68 - 1.5 (- 7.2 to 4.1)    0.59 0.08 
Self-efficacy symptoms (10 - 100, 100 = high) 
  IA                             62.8 (13.6)   6.2 (- 9.1 to - 3.2) < 0.001   6.7 (- 9.8 to -3.6) < 0.001 0.53 
 FMS 55.5 (15.4) - 0.2 (- 4.7 to 5.1)    0.95   3.3 (- 8.4 to 1.9)    0.21 0.19 
Self-care ability (VAS 0 - 10, 0 = very good) 
  IA                             32.5 (23.3) - 6.9 (1.7 to 12.0)    0.01 - 8.5 (3.6 to 13.5)  < 0.001 0.41 
  FMS 37.2 (27,4)   2.9 (- 9.0 to 3.3)    0.36   3.9 (-12.9 to 5.1)    0.39 0.13 
Pain (VAS 0 - 10, 0 = very good) 
  IA                             45.7 (24.1) - 7.1 (1.3 to 12.8)    0.02 - 6.7 (0.8 to 12.7)    0.03 0.27 
  FMS 60.1 (18.8) - 1.9 (- 4.4 to 8.1)    0.55 - 2.0 (- 6.0 to 9.9)    0.62 0.01 
Fatigue (VAS 0 - 10, 0 = very good) 
  IA                             57.0 (28.0) - 4.8 (- 1.0 to 10.6)    0.10 - 8.7 (2.4 to 14.9)    0.007 0.33 
  FMS 74.6 (20.5) - 2.7 (- 4.3 to 9.6)    0.44 - 7.0 (- 1.1 to 15.2)    0.09 0.27 
PGA (VAS 0 - 10, 0 = very good) 
  IA 46.9 (22.9) - 5.3 (- 0.2 to 10.8)    0.06 - 3.8 (- 1.4 to 8.9)    0.15 0.18 
  FMS 60.1 (19,4) - 0.2 (- 6.4 to 6.7)    0.96 - 0.3 (- 6.1 to 6.6)    0.93 0.01 
*Paired sample t-tests, SRM = Standardised response mean (< 0.2 = trivial, 0.2 – 0.49 = small, 0.5 – 0.79 = moderate,  80 = 
large), IA = Inflammatory Arthritis, FMS = Fibromyalgia syndrome, VAS = Visual Analogue Scale, PGA = Patient Global 
Disease Activity, 
 
 
Table 6: Predictors of change in psychological distress at one-year follow-up 
  Bivariate analysis* Multivariate analysis* 
Predictor variables Coefficient 95% CI P-value Coefficient 95% CI P-value 
Wellbeing (VAS) 0.12 (0.03 to 0.21) 0.01    
Fatigue (VAS) 0.09 (0.02 to 0.17) 0.03 0.17 (0.08 to 0.26)  <0.001 
Diagnosis:   0.02      
   IA 5.98 (1.07 to 10.89)  9.74 (4.69 to 14.79) <0.001 
   FMS  reference    reference     
* Linear regression analysis, IA = inflammatory arthritis, FMS = fibromyalgia syndrome, VAS = Visual 
Analogue Scale (0 - 100, 0 = no pain/fatigue/high wellbeing) 
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5.2 Persons with rheumatic diseases’ experiences from 
participation in the VTP (paper II) 
A total of 69 patients took part in the focus groups. Five main categories were 
identified from the data analyses: 1) recognizing oneself as both ill and healthy, 2) 
recognizing own emotions, 3) awareness of own needs, 4) being part of a community 
and 5) being recognized as a credible patient. The first three categories were related 
to the type of influence participants experienced from the intervention, and the last 
two categories were related to the processes by which influences arouse. Quotes that 
illustrate each category are shown in Table 7. 
Table 7: Categories and illustrating quotes identified in the focus group interviews 
Category Quotes 
1. Recognizing 
oneself as both 
ill and healthy 
“For me personally, it is important not just to be an ill person. I mean the fact that 
I am a whole person even though I have a chronic disease. Yes, they [the topics in 
the VTP] reminded me of it. I got it confirmed that I really am a whole person in 
spite of being an ill person. I realize this, but it really makes a difference to work 
on it. I am not only a disease, I am so much more” (IA-group 5). 
“I have never liked my weak side, like needing rest and care and such, I have 
never really liked this. Now I just have to accept it. And in fact I really like this 
side of myself, it is more human, I think it has completely different facets” (FMS-
group 2). 
2. Recognizing 
own emotions 
“It has been very important to acknowledge my sorrow over no longer being 
healthy.  It is a fundamental feeling, as we are of course in the middle of life and 
everyone else is healthy and they expect that we are too, and there we are feeling 
desperate at having lost something that is so valuable” (FMS-group 2). 
“I feel such a lack of energy that I haven't been able to work. This has been a great 
sorrow for me personally… As I am so young, this should not break me down, so 
I have done my best, cried, and hoped that no-one would notice that I wasn’t 
well... In fact my problem was that it was difficult to accept my situation. I kinda 
felt that I was not worth so much anymore, couldn't cope with my job any more” 
(FMS-group 1). 
“I have started to understand that anger can be very positive and that I need it in 
any case, because then you get rid of tension, and in a way you may get rid of a 
big heavy backpack, like we were talking about, and as I said, now I only have a 
small nylon knapsack. Anger has kinda developed into something that lets you set 
limits, and you are even allowed to say no” (IA-group 3). 
3. Awareness of 
own needs 
“Help! I had said ‘no’ to someone. I don't usually do this. So it was very peculiar 
to think about after I had done it.  ... I usually only say ‘yes’ …, but now I have 
been better at thinking of myself ...  Those round me respect me when I say ‘no’ ... 
absolutely, they have always said that I should think more of myself. In fact, I 
really said ‘no’ before, but with a really bad conscience and stomach-ache, but 
now I say ‘no’ with a far better conscience” (IA-group 7). 
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Table 7: Continued 
Category Quotes 
4. Being part of 
a community 
“What has been most important for me has been meeting other people with the 
same condition, or at any rate with a chronic condition that affects their daily life, 
and then being allowed to talk about all the negative feelings that I have had, all 
my defeats, my anger, disappointments and vulnerability, which have been 
difficult to cope with outside this group” (IA-group 2). 
“I'd never met anyone with this diagnosis before and I felt very much on my own. 
Now, I know several others, and I don't feel so alone any more” (FMS-group 1). 
5. Being 
recognized as a 
credible patient 
“When I got this [invitation] letter, I thought, is there really anyone who takes this 
seriously and believes me? This was an incredible experience for me” (FMS-
group 1). 
“It is like a burden being lifted off me. A heavy backpack, to put it like that. I am 
not lazy, I am ill and I can do something about it, as now that I know what it is, I 
have completely different resources, masses of energy has been released” (FMS-
group 2). 
 
The VTP had enhanced participants' recognition of their disease-related emotions and 
helped them to relate more actively to their own needs. The study illuminated how 
the VTP, by combining topics related to life rather than the disease with awareness 
(mindfulness) and creative exercises and adaptive emotional expression, had 
enhanced emotional wellbeing and adaptive coping behaviour in patients with various 
rheumatic diseases. 
5.3 Validity and responsiveness of the Emotional Approach 
Coping Scale in Norwegian persons with rheumatic 
diseases (paper III) 
A total of 220 patients were included in the cross-sectional study; 118 in group 1, 36 
in group 2 and 66 in group 3. Group 1 (patients attending the rheumatology clinics) 
had a significantly higher proportion of men (p < 0.001) and significantly longer 
disease duration than the two others (p < 0.001). Group 2 (patients attending the 
VTP) were significantly younger than the two other groups (p = 0.03). No significant 
differences were found for other variables assessed at baseline. 
The EAC had low levels of missing data, ranging from 5.7% to 1.9%, for items 
relating to Emotional Processing and Emotional Expression, respectively. Mean item 
scores (SD) ranged from 2.51 (0.89) to 3.32 (0.66). Results from principal component 
analysis supported the two subscales, Emotional Processing and Emotional 
Expression, which both had high Cronbach's alphas of 0.92 and 0.90, respectively 
(Table 8). These two components accounted for 62.7 % of the total variance. 
Tabell 8: Component loading and Cronbach's alpha for the Emotional Approach Coping 
Subscales (Emotional processing and Emotional Expression) 
Scale/item Component loading* 
Cronbach’s 
alpha 
Emotional Processing  0.90 
I take the time to figure out what I'm really feeling 0.71 0.88  
I delve into my feelings to get a thorough understanding of 
them 0.81 0.88  
I realize that my feelings are valid and important 0.58 0.90  
I acknowledge my emotions 0.46 0.90  
I work on understanding my feelings 0.84 0.88  
I explore my emotions 0.80 0.88  
I find a way to understand my emotions better 0.80 0.88  
I look closely at the reasons for my feelings 0.85 0.88  
Emotional Expression  0.92 
I take time to express my emotions 0.62 0.91  
I let my feelings come out freely 0.79 0.91  
I allow myself to express my emotions 0.85 0.90  
I feel free to express my emotions 0.75 0.91  
I express the feelings I am having 0.86 0.90  
I find a way to express my emotions 0.62 0.92  
I let my feelings out 0.87 0.90  
I get my feelings out in the open 0.82 0.90  
*Emotional  processing and emotional  expression had eigenvalues of 2.79 and 7.25 respectively 
 
As hypothesised the EAC was positively correlated with approach-oriented items in 
the BACQ in the range 0.17- 0.50. There were no significant correlations between the 
EAC scales and the avoidance-oriented items in BACQ. The EAC Expression scale 
had a low and significant negative correlation with the GHQ-20 of - 0.13, i.e. higher 
emotional expression was associated with lower distress, which supported the 
hypothesis that the EAC items do not measure aspects of emotional distress.  
Twenty-six (72%) of the included patients in the VTP and all included patients in the 
SMP completed the questionnaire after the intervention. As hypothesised the EAC 
scores increased more in the VTP group than in the SMP group. In the VTP group, 
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both EAC Processing and EAC Expression increased significantly, with SRMs 0.47 
and 0.70, respectively. There were no significant changes in the EAC scales in the 
SMP sample at follow-up (Table 9). 
Table 9: Responsiveness of the EAC in the VTP (n = 26) and the SMP (n = 66) calculated by 
paired samples t-tests 
  Baseline Follow-up Change scores SRM
  mean (SD) mean (SD) mean (SD)   
EAC processing (1 - 4, 4 = high processing) 
              VTP (15 weeks) 3.12 (0.60) 3.39 (0.64) - 0.27 (0.58)* 0.47 
              SMP (1 week) 2.83 (0.66) 2.93 (0.66) - 0.10 (0.52) 0.19 
EAC expression (1 - 4, 4 = high expression) 
              VTP (15 weeks) 2.69 (0.64) 3.06 (0.56) - 0.37 (0.53)** 0.70 
              SMP (1 week) 2.76 (0.63) 2.82 (0.57) - 0.06 (0.45) 0.13 
VTP = Vitality Training Program (15 weeks), SMP = Self Management Program (one week) 
* P < 0.05, ** P < 0.001. Values refer to statistical differences in mean scores between baseline and 
post-intervention, SD = standard deviation, SRM = standardised response mean 
 
The EAC was found to be acceptable and valid for measuring emotional processing 
and expression in Norwegian patients with rheumatic diseases. The EAC scales were 
responsive to change in the VTP, which was considered to be an intervention that 
promoted emotional awareness. 
5.4 Clinical effects of the VTP in persons with inflammatory 
rheumatic joint diseases (paper IV) 
Seventy-three persons were randomised, 37 to the VTP and 36 to the control group. 
The VTP and control groups were well matched at baseline with regard to 
demographic and disease variables and all outcome measures; p-values ranged from 
0.13 to 0.95. Ten persons in the control group and 13 in the VTP group exceeded the 
GHQ-20 threshold of 23.  
Sixty-eight persons (93%) were available for follow-up post-treatment (34 in each 
group), and 67 (92%) completed the 12-month assessments (34 in VTP and 33 in 
control). Significant treatment effects in favour of the VTP were found post-
treatment, and effects were maintained at 12 months in the primary outcome 
psychological distress and the co-primary outcomes self-efficacy pain and symptoms 
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and emotional processing. Treatment effects in psychological distress post-treatment 
and 12 months had effect sizes of 0.73 and 0.58, respectively. Other effect sizes 
ranged from 0.92 (self-efficacy symptoms) to 0.43 (emotional processing). No 
significant between-group differences were found in emotional expression (Table 
10). In the VTP group, the number of persons exceeding the GHQ-20 threshold of 23 
was reduced from 13 (36%) at baseline to 2 (6%) at 12 months, compared with from 
10 (29%) to 8 (24%) in the control group (p = 0.045).  
Significant treatment effects in favour of the VTP were also found post-treatment and 
at 12 months in the secondary outcomes fatigue, self-care ability and wellbeing. In 
the VTP group, improvement in fatigue was increased at 12 months, whereas the 
control group was unchanged from baseline. Effects in pain and the patient global 
assessment of disease activity did not reach statistical significance (Table 10). 
The results show that the VTP can be considered a beneficial complement to existing 
treatment for patients with inflammatory rheumatic joint diseases, particularly for 
people who experience heightened psychological distress and fatigue. 
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Table 10: Mean (95% CI) scores and treatment effects (differences post-treatment and 12 months) 
and overall p-values estimated with mixed models linear repeated measures analysis* 
VTP Group Control group Effect (95% CI) p-value
Primary outcome  
Psychological distress (GHQ-20) (0–60, 0 = no distress)** 0.002 
Baseline 19.9 (17.8 to 22.1) 19.8 (17.5 to 22.0)   
Post-treatment 15.7 (13.5 to 17.9) 20.4 (17.4 to 23.4) -4.7 (-7.6 to -1.8)  
12 months 14.5 (12.8 to 16.2) 18.4 (15.7 to 21.2) -3.7 (-6.3 to -1.1)  
Co-primary outcomes  
Self-efficacy pain (10–100, 100 = high)†  0.001 
Baseline 55.4 (50.3 to 60.6) 60.9 (55.7 to 66.4)   
Post-treatment 65.9 (61.7 to 70.0) 61.0 (55.3 to 66.7) 8.2 (2.1 to 14.2)  
12 months 67.8 (62.4 to 73.3) 61.5 (55.8 to 67.3) 9.1 (3.4 to 14.8)  
Self-efficacy symptoms (10–100, 100 = high)† < 0.001 
Baseline 64.2 (59.8 to 68.6) 66.6 (61.2 to 72.1)   
Post-treatment 74.3 (70.9 to 77.7) 68.5 (62.7 to 64.4) 8.8 (3.0 to 14.6)  
12 months 73.3 (68.9 to 77.6) 62.8 (56.4 to 69.1) 13.1 (6.7 to 19.3)  
EAC processing (1–4, 4 = high) † < 0.001 
Baseline 2.7 (2.5 to 3.0) 2.8 (2.6 to 3.1)   
Post-treatment 3.2 (3.0 to 3.4) 2.9 (2.7 to 3.1) 0.4 (0.29 to 0.6)  
12 months 3.1 (2.9 to 3.3) 2.9 (2.6 to 3.1) 0.3 (0.02 to 0.5)  
EAC expression (1–4, 4 = high)† 0.191 
Baseline 2.6 (2.4 to 2.9) 2.6 (2.4 to 2.8)   
Post-treatment 3.0 (2.8 to 3.2) 2.8 (2.6 to 3.0) 0.2 (-0.02 to 0.4)  
12 months 2.9 (2.7 to 3.1) 2.8 (2.6 to 3.1) 0.04 (-0.2 to 0.3)  
Secondary outcomes  
Pain (0–10, 0 = no pain)** 0.064 
Baseline 4.7 (4.1 to 5.3) 4.6 (3.9 to 5.3)   
Post-treatment 4.6 (4.1 to 5.2) 4.9 (4.1 to 5.7) -0.4 (-0.97 to 0.22)  
12 months 3.9 (3.3 to 4.5) 4.5 (3.8 to 5.1) -0.6 (-1.28 to 0.02)  
Fatigue (0–10, 0 = no fatigue)** 0.002 
Baseline 5.2 (4.5 to 5.9) 4.9 (4.1 to 5.7)   
Post-treatment 4.8 (3.9 to 5.7) 5.2 (4.4 to 6.1) -0.8 (-1.5 to -0.2)   
12 months 4.1 (3.3 to 5.0) 4.9 (4.1 to 5.7) -1.1 (-1.8 to -0.4)  
PGA (0–10, 0 = no activity)** 0.069 
Baseline 4.6 (4.0 to 5.1) 4.5 (3.9 to 5.2)   
Post-treatment 4.5 (3.9 to 5.0) 4.8 (4.0 to 5.5) -0.3 (-0.89 to 0.23)  
12 months 3.8 (3.2 to 4.4) 4.5 (3.9 to 5.2) -0.7 (-1.38 to -0.05)  
Self-care ability (0–10, 10 = very good)** < 0.001 
Baseline 7.0 (6.4 to 7.6) 6.9 (6.3 to 7.4)   
Post-treatment 7.7 (7.1 to 8.3) 6.4 (5.8 to 7.0) 1.2 (0.7 to 1.7)  
12 months 7.7 (7.1 to 8.3) 6.6 (6.0 to 7.2) 1.0 (0.5 to 1.6)  
Wellbeing (0–10, 10 = very good)** < 0.001 
Baseline 6.5 (6.0 to 7.0) 6.3 (5.9 to 6.8)   
Post-treatment 7.0 (6.5 to 7.5) 6.2 (5.6 to 6.7) 0.8 (0.2 to 1.3)  
12 months 7.4 (7.0 to 7.9) 6.7 (6.2 to 7.2) 0.6 (0.1 to 1.2)  
* Adjustment for the baseline mean values and gender, age, disease duration, education, and civil status, ** Five 
repeated measures at baseline and follow-ups, † Measured once at baseline and follow-ups, GHQ = General Health 
Questionnaire, EAC = Emotional Approach Coping, PGA = Patient global assessment of disease activity 
 71
6. Discussion
6.1 Methodological aspects 
6.1.1 Study designs 
Four different study designs were used: longitudinal pre – post-test, qualitative, cross-
sectional and randomised controlled design. 
6.1.1.1 Longitudinal design 
In this design data are collected prospectively on two or more occasions. It is 
appropriate for studying variable or phenomenon dynamics over time and for 
generating hypotheses about associations between an applied intervention and a 
variable (151). If no parallel control group is included, it is not possible to conclude 
that the changes are produced by the intervention. In our study, the design was used 
to evaluate possible effects of the VTP and generate hypotheses that could be further 
tested in a controlled trial (paper I). It was also used to test the responsiveness of the 
EAC (paper III).  
In prospective studies the number of measurements and follow-up duration varies. 
The latter is usually more than three and seldom more than 15 months when 
evaluating psychosocial interventions months (see Table 1). A main issue in our 
study was to evaluate if the VTP had any long-term impact on participants’ health 
and wellbeing. We expected that integration of new coping strategies in participants' 
lives would take some time. Therefore follow-up duration could not be too short. At 
the same time, longer time before the follow-up assessments increased the risk that 
other events could influence participants’ lives. Balancing these considerations, the 
follow-up time was set to 12 months. 
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6.1.1.2 Qualitative design 
This design allow for in-depth descriptions of participant perspectives and a broader 
understanding of how they make sense of their experiences (181). We used focus 
groups to explore how the participants experienced the VTP in terms of its possible 
influences on their wellbeing and coping behaviour and the processes by which these 
influences arouse (paper II). Qualitative focus group interview is a common method 
of data collection when the aim is to evaluate strengths and weaknesses of a program 
(182;183). Following up the quantitative data collection in the pre – post-test study 
by qualitative focus group interviews, enabled participants to speak for themselves 
and added descriptive and explanatory data to the statistical data, and thus deepened 
our understanding of how the participants created meaning from their experiences 
(181). 
6.1.1.3 Cross-sectional design 
The cross-sectional design is considered a practical and relatively easy way to collect 
large amounts of data with moderate resources because data are collected at a single 
time point only. It is appropriate for describing the status of a phenomenon or 
investigating the associations between phenomena at a fixed time-point (151). 
Because the respondents are contacted only once, the chance of a high response rate 
increases. A limitation is the lack of opportunity to study the stability of findings over 
time. 
In our study this design was used to test the factor structure, internal consistency, 
construct validity and the applicability of the EAC (paper III). For this purpose the 
EAC was tested together with other scales at the same time point and a cross-
sectional design was considered appropriate (174). 
6.1.1.4 Randomised controlled design 
This design is considered the ‘gold standard’ for evaluating intervention effects 
(184). In high quality RCTs, participants are randomly allocated to intervention or 
control arm, with the trial arm concealed to both participants and researchers if 
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possible. The study should be appropriately powered to find significant treatment 
effects, and intention to treat analysis should be performed. The participants should 
also be representative of the population for which the results are intended to be valid 
(185). 
There are major obstacles to performing high quality non-pharmacological RCTs. 
Placebo or sham therapy is practically impossible, making blinding difficult or most 
often impossible. Participants will therefore know which arm they are allocated to 
and what the preferred intervention is. Being allocated to ‘routine care’ may be a 
disappointment and lead to a performance bias. Also, contamination may be 
introduced if the control group participants try similar interventions for themselves. 
The intervention group will receive considerable attention that may exaggerate the 
effects. Because the participants may be reluctant to being allocated to the control 
group, recruitment is often difficult, resulting in a selection bias (186). Therefore the 
studies may often be considered as pragmatic, i.e. they are conducted in a real-world 
context with a real-world spectrum of participants, when intending to evaluate 
whether the intervention improves clinical outcomes. 
Despite these obstacles and limitations, we conducted a pragmatic randomised 
controlled trial to evaluate VTP effects. With the intent to compensate for negative 
effects from being allocated to routine care only, control group participants received a 
CD with mindfulness-based home exercises for individual voluntary use. They were 
also informed that they would be invited to VTP participation after completed data 
collection. While VTP participants or group facilitators could not be blinded, both 
assessors and the statistician, who conducted the primary analyses, were blinded for 
group allocation. 
6.1.2 Study samples 
The extrapolation of results from the study sample to the population of interest 
depends on the representativeness of the sample (187). Selection of study sample and 
sample sizes will therefore influence the external validity of the study. Group 
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interventions, such as the VTP, demand much more time and efforts from the 
participants than taking medications, and interventions that address emotional 
reactions to the disease and its consequences can prove challenging (188;189). 
Recruitment may therefore be difficult, and it is often necessary to approach a large 
amount of people to include sufficient number of participants in a trial, especially if 
the trial includes a control group. Thus, in pragmatic trials, which aim to represent 
how an intervention operates in reality outside the research setting, representativeness 
may be difficult to obtain and self-selection may be a source of selection bias. 
6.1.2.1 Sample included in the pre – post-test and the focus group 
studies
The implementation of VTP groups at the rheumatology departments started in 
January 2003. Patients who visited the rheumatology outpatient clinics and the 
rheumatology in-patient wards were informed about the VTP courses and invited to 
attend open information meetings. People who were interested after the information 
meetings, enrolled in the VTP. Persons who met the inclusion criteria, i.e. confirmed 
rheumatologic diagnosis; age 20 years or older and good understanding of Norwegian 
language, were then asked to participate in the study. Thus, a selection bias of 
particularly interested persons may have been introduced. 
Patients with a wide range of inflammatory and non-inflammatory rheumatologic 
diagnoses were recruited for the study. The majority had RA, and the percentage 
distribution of diagnoses was probably representative for patients visiting each 
department. An exception was the two departments that, due to a large amount of 
referrals of FMS patients to their clinics, recruited only patients with FMS.  
The sample had a skewed gender distribution. The proportion of men was relatively 
lower than the gender distribution of the diseases, which gives reason to ask whether 
the VTP attracts more women than men. The RA patients were slightly younger 
compared to other samples drawn from the Oslo RA Register in the same time period, 
whereas the AS patients were comparable to the AS Register. Our sample had slightly 
shorter disease duration and was less disabled than the register patients (15;40;190). 
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However, the levels of pain, fatigue and psychological distress were relatively high, 
indicating that the included patients might have been in need for the intervention, and 
thus had a potential for improvement. 
Further, because we included only people with good understanding of Norwegian 
language, people with non-Norwegian cultural background were probably 
underrepresented. Recognising that there is a relatively large group of immigrants 
with rheumatic diseases in Norway, adaptation of the VTP to these groups of patients 
should be investigated in further research. 
Participants in the focus group interviews, i.e. the first ten VTP groups, did not differ 
significantly from the whole sample in any variables. However, the objective of the 
qualitative study was not to generalise the results, but to get a deeper understanding 
of the participants' experiences. The criterion of representativeness is therefore not 
applicable. Instead, to illuminate different understandings and meanings, participants 
should reflect a range of the total study population (“purposive sampling”) 
(181;183;191). In our focus groups the proportions of males and females were similar 
to the whole sample. They represented a range of ages and disease duration; they 
were single and married, working and non-working participants. 
Number of participants in qualitative studies is normally not predefined. Sampling 
usually stops when a thorough understanding of the phenomenon under study has 
been reached (often called “saturation”) (191). Our inclusion stopped when we had 
interviewed ten groups, which had been facilitated by different group leaders, and 
which represented five rheumatology departments. When we read the transcripts from 
these interviews, we considered that the content was sufficient to give us a broad 
understanding of participant experiences. 
6.1.2.2 Samples included in the study of measurement properties of the 
EAC
Estimates of validity are dependent upon the nature of the people being measured, 
and to a greater or less degree, the circumstances under which they are being assessed 
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(174). The sample included in this validation study was consecutively recruited from 
patients who attended regular consultations at rheumatology inpatient, outpatient or 
day clinics at four different rheumatology departments. In addition, two samples of 
patients attending four VTP groups and five diagnosis-specific SMP courses were 
included in both the cross-sectional validation study and the responsiveness study. 
There was a slightly higher proportion of IA patients and men in the consecutive 
sample compared to the two other samples, probably reflecting the patients attending 
regular rheumatology consultations at these clinics. In the sample included in the 
responsiveness study, the participants attending the VTP were significantly younger 
than the participants attending the SMP. The SMP did not include RA patients and 
had a higher proportion of FMS patients, limiting the representativeness of this 
sample. 
Although there are limitations to representativeness of the samples included in this 
study, the total sample reflected the approximate distribution of rheumatologic 
diagnoses among patients attending regular consultations at rheumatology 
departments in Norway. They were comparable with the sample included in the 
previous pre – post-test study as regard to age and disease duration. Because the EAC 
is a generic questionnaire, the variety of diagnoses should not influence the results. 
However, the results may have been influenced by other patient characteristics, such 
as levels of symptoms, disease severity and other health related outcomes, which 
were not measured in this study. The relatively small samples may also limit the 
interpretation of the results, especially in the responsiveness study. Further testing of 
the EAC based on larger samples is therefore recommended. 
6.1.2.3 Sample included in the randomised controlled trial 
Based on the results from the pre – post-test study, only patients with inflammatory 
rheumatic joint diseases were included in the RCT. Participants were recruited from 
three rheumatology departments in south-eastern Norway between March 2007 and 
June 2009. The VTP was already implemented at the departments, and there were 
waiting lists for participation. When we asked people on the waiting lists to 
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participate in the RCT, several refused because they did not want the risk of being 
allocated to the control group and having to wait another year for the intervention. 
We therefore approached registry patients at one of the hospitals (The Oslo RA 
Register and the AS Register at Diakonhjemmet Hospital, see section 4.4.3), who did 
not regularly visit the clinics, and whom we assumed had not heard about the VTP 
before. Consequently, we did not know if they needed such an intervention at the 
time they were approached. In addition, one of the departments that previously had 
included only FMS patients, accepted to recruit people with IA, who regularly visited 
their clinics. 
A total of 814 people were invited by letter to attend the information meetings, 152 
accepted the invitation and 113 attended the meetings. After having received 
information, 73 persons consented to participate in the study. It is likely that this 
sample consisted of highly motivated persons, who recognised their need for the 
intervention, and who were willing to invest their time and effort in participation. 
As regard to age and gender distribution, the sample was comparable to samples 
included in other relevant studies (113;121;122;134). The sample had higher level of 
education than the general Norwegian population (15), but only about forty percent 
had paid work, which may reflect the relatively long disease duration. The work 
disability was close to what was found in a Norwegian cohort of RA patients with 
approximately the same disease duration (192), but higher than a cohort from the AS 
register (15). The levels of pain, fatigue and patient-reported disease activity were 
relatively high, but slightly lower than in the previous pre – post-test study. More 
than 32% of the participants were characterised as highly distressed. Considering 
these characteristics, the sample may be representative for those who experience a 
relatively high disease impact and are motivated to work on having a better life with 
their disease. 
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6.1.3 The Vitality Training Program 
As outlined in section 2.3 the VTP was initially developed for persons with chronic 
musculoskeletal pain (143). The overall goal of the present thesis was to evaluate 
whether this kind of intervention could be effective also in patients with 
inflammatory rheumatic diseases. To adjust the program for IA patients, we 
collaborated with two persons who had long-term experience of living with RA. We 
also tested the program in two pilot groups and made further adaptations according to 
responses from the participants. An example of alteration from the original program 
is that the topic ‘sorrow’ was included. The program was also shortened from 12 to 
10 sessions to make it more feasible. 
A critical issue is whether the VTP was carried out in the same way in all the groups. 
To ensure that all topics and methods were implemented as similar as possible, we 
prepared a manual with thorough descriptions of the program. Equally important was 
the training of the group facilitators in a comprehensive one-year education, 
comprising six three-day workshops, plus home assignments and completed by a 
practical examination. However, group processes will always be influenced by the 
facilitators’ personal qualifications as well as the interactions between group 
participants, and therefore some variations between the groups are likely to exist. 
In the RCT (paper IV), our primary goal was to investigate whether the VTP had 
added value beyond routine care. Concerns about the routine care control group have 
been raised in section 6.1.1.3. We realise that routine care do not control for the effect 
of the attention that the intervention group receives. However, we consider the 
attention and the social support from the group facilitators and other group 
participants to be embedded in the VTP and part of what we are evaluating. To 
reduce a possible negative effect of no attention, the control group received a CD 
with mindfulness-based home exercises for voluntarily use. Because we did not 
expect the CD to have similar effects as group participation, we did not ask them to 
register their use of it. Thus, we have not been able to control for possible effects of 
the CD. However, informal feedback from control group participants indicates that 
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they had not experienced the usefulness of the CD before they participated in the 
VTP. 
An alternative to routine control might have been to compare the VTP to other group 
interventions, such as “Living a Healthier Life” (“Å leve et friskere liv”) or a CBT 
intervention, to evaluate the comparative effectiveness of these interventions. This is 
an issue for further studies. 
6.1.4 Methods of data collection 
6.1.4.1 Self-reported measures 
All data in this study, except for age, diagnosis and disease duration, were self-
reported and collected by questionnaires. The basic assumption of patient-reported 
data is that knowledge about subjective experiences, such as emotional wellbeing, 
pain and fatigue is best obtained by asking the person of interest. There is of course a 
risk of response bias, i.e. respondents may either underreport or overestimate their 
symptoms, and thus the effect of interventions. However, research comparing 
physician-reported and patient-reported assessments has concluded that 
improvements in signs and symptoms of active RA in randomised, placebo-controlled 
trials is equally or better reflected by patient-reported measures (193-196). The 
strength of the self-reported outcomes is that they reduce the effect of observer bias. 
A limitation in this study may be that the core set for disease activity measurement 
was not included. However, we did not expect that the intervention would influence 
disease activity. 
Completing questionnaires may be time consuming and strenuous, and the quality of 
the data may be influenced by the length and order of the questionnaires. Thus we 
had to balance the need for information with making the questionnaire reasonably 
short. We also considered the order of the different questionnaires included in the 
comprehensive package. Some has recommended that the broader and less sensitive 
questionnaires should be placed before the diseases specific and the more sensitive 
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questions (197), whereas others have not found any evidence of order effect when 
different measures are combined (198). In this project we used two different orders. 
In the pre – post-test study, the questions related to the diseases were placed first. In 
the RCT, we started with the outcomes that were measured five times and continued 
with the questions related to emotions and self-efficacy, because we wanted to 
introduce the participants to the most relevant outcome measures first. The response 
rates were relatively high in both studies and did not seem to be influenced by the 
order of the questions. It is not possible to say if answering questions about 
psychological distress and symptoms first may have influenced the participants’ 
further answers about for example emotional responses and self-efficacy. 
6.1.4.2 Telephone interviews 
The mode of data collection has been found to influence patient responses (199;200). 
Feveile et al found that the overall response-rate was similar for questionnaires and 
telephone interviews, but the numbers of missing items were lower in telephone 
interviews. For health assessment items extreme response categories as well as more 
positive reporting were used more frequently among telephone respondents (200). 
The rationale for using telephone interviews in our study was to increase the response 
rate. Because we wanted to collect data five times at two-week intervals at each 
assessment point, we assumed that the burden on patients would be less if they were 
called, than if they were asked to fill in and return questionnaires. We may consider if 
a response bias towards a more positive rating may have occurred. Because of the 
frequency of the interviews, there is also a risk that the responses are influenced by 
the respondent’s memory, a recall bias. However, the interviewers emphasised that 
the questions should reflect the respondent’s condition “during the last two weeks” 
(GHQ-20) or “during the last week” (NRSs). 
6.1.4.3 Focus group interviews 
In qualitative interviews, understanding the participant's context is a central concern. 
The interviewers therefore need to identify their own context and predispositions in 
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order to understand how their own views and beliefs may influence the interactions 
they have with the participants (181). In our study, three different interviewers 
moderated the focus groups. All were experienced interviewers with good knowledge 
of the VTP, who had not facilitated any of the groups. The interviewers had discussed 
their predispositions in advance, such as being influenced by their own interests in 
and previous experiences from the VTP.  
A general problem in qualitative studies is that patients might be liable to say positive 
things in order to please the interviewer. The interviewers came to an agreement on 
aiming to create an open conversation, in which all participant views could be 
comprehensively explored and to be particularly responsive to any critical issues as 
they arose within the group. The group facilitators did not take part in the interviews, 
and the participants were encouraged to elaborate on how interactions with the group 
facilitators had influenced their experiences. Focus groups explicitly use group 
interaction as a part of the method. It can also be objected that group interviews 
favour the most articulate persons, and group norms may silence individuals with 
divergent opinions. However, studies have shown that focus groups encourage 
participation from people who are reluctant to be interviewed on their own or who 
feel that they have nothing to say, and that group processes can help people explore 
and clarify their views in ways that would be less easily accessible in one to one 
interview (183). 
Interviewing is an evolving process during which the interviewers acquire new 
insights into the phenomenon of study that can subsequently influence follow-up 
questions and may narrow the focus in succeeding interviews (201). This might have 
happened in our study, which included ten group interviews. However, the fact that 
three different interviewers conducted the interviews reduced this risk of selective 
awareness. Also, the semi-structured interview guide ensured that the same topics 
were explored in each group. To ensure confidentiality, no names were used during 
the interviews. 
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6.1.5 Outcome measures 
When evaluating effects of interventions in clinical trials, the outcome measures must 
be able to detect a meaningful or clinically relevant change over time. This ability is 
referred to as the instruments’ responsiveness (169;177). An important criterion for 
choosing instruments in order to detect change in physical or emotional health status 
is whether they are generic or disease-specific. Generic measures seek a broad 
perspective that is not specifically related to the particular disease. Therefore, they 
allow investigators to compare health status across different diseases and 
interventions. Disease-specific measures focus on aspects of health that are relevant 
to a particular group of patients. Thus, they provide the opportunity to tap more 
precisely intervention-related improvements in domains of health that may have been 
deteriorated due to the disease (176;177). Studies have indicated that in RCT’s with a 
true underlying effect, specific instruments are more responsive to change than 
generic instruments (176). 
In our studies, we included individuals with various rheumatic diseases. We therefore 
had to choose instruments, which were broad enough to capture aspects of health that 
are common across the different diagnoses, and sensitive enough to detect clinically 
relevant changes in the domains that the VTP was most likely to impact. Strengths 
and weaknesses of the main outcome measures are discussed below. 
6.1.5.1 The General Health Questionnaire (GHQ) 
The GHQ is a widely used screening instrument for detecting psychological distress.  
Unlike other screening instruments for psychological disorders, the GHQ is balanced 
between positively phrased items, indicating psychological health, and negatively 
phrased items, indicating psychological distress. The respondents are requested to 
compare their current status with what they consider as their ‘normal’ condition. 
There are several versions of the GHQ. The 20-item version, which we have used in 
our studies, has been validated in a Norwegian sample of accidentally injured trauma 
patients. It has proved to provide acceptable values for sensitivity and specificity to 
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detect serious psychological distress at a cut-off between 23 and 24 (sum score) 
(160;161). The GHQ-20 has also been found to be responsive to changes in mental 
health status following stressful events and during the course of rehabilitation, using a 
Likert scoring procedure (160;161). 
A possible limitation concerning the use of the GHQ in persons with chronic somatic 
diseases is that they may find it difficult to consider what their ‘normal’ or ‘usual’ 
condition is, especially when their condition is fluctuating. Some persons will tend to 
compare their current condition to how they perceived their health status before they 
got ill, and hence, they will always be under a certain distress. One may also assume 
that what individuals consider as ‘normal’ may change as they adjust to the 
distressing experiences from the disease. Careful interpretation of the scorings is 
therefore required. 
6.1.5.2 The Arthritis Self-Efficacy Scale (ASES) 
The ASES is an arthritis-specific instrument, comprising three subscales; self-
efficacy pain, self-efficacy function and self-efficacy other symptoms (85). The 
instrument is found to have appropriate validity and reliability in arthritis patients and 
is frequently used as an outcome measure in self-management interventions, in which 
self-efficacy believes are found to be modifiable (109).  
Although the VTP was not designed to influence participants’ self-efficacy believes 
directly (see section 2.2.2 and 2.3.1), we considered the ASES to be a relevant 
instrument to measure if the VTP could strengthen the participants’ self-efficacy and 
for comparing the effects of the VTP with other interventions. Based on the results 
from the pre – post-test study, we included the ASES as a co-primary outcome in the 
RCT. Because we did not expect the VTP to influence physical function, we omitted 
the self-efficacy function subscale.  
The ASES is found to be correlated with favourable health status changes (85;90), 
and consequently, we might have included it as a mediating variable rather than an 
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outcome. However, in our study we wanted to measure the direct effects of the VTP 
on perceived self-efficacy and therefore included it as an outcome. 
6.1.5.3 The Emotional Approach Coping Scale (EAC) 
The rationale for including the EAC is outlined in section 2.2.4.1, and the 
measurement properties in Norwegian patients with rheumatic diseases were 
evaluated in paper III. Some limitations of the EAC need to be mentioned. First, the 
EAC was not evaluated for test – retest reliability in our study, which is 
recommended for the use of EAC in further studies. However, satisfactory test – 
retest reliability and inter-judge reliability have been documented in other studies 
(83;101). Second, an underlying assumption is that individuals are aware about how 
they relate to their emotions and are able to report that properly. It may be 
hypothesised that when individuals have completed an intervention that focus on 
awareness and expression of emotions, they may have changed the way they perceive 
their ability to process and express emotions. This may influence the instrument’s 
responsiveness to change. However, in our validation study (paper III) the EAC was 
found to be responsive to change after the VTP. Third, the EAC items are of a 
general nature and do not address specific emotions. Thus, the instrument does not 
give any information about the more specific emotional reactions that may be 
relevant responses to chronic diseases, such as for example anxiety, anger or sadness 
(101). 
6.1.5.4 Visual Analogue Scales (VAS) and Numerical Rating Scales 
(NRS)
In paper I, VASs were used for measuring pain, fatigue, patient global disease 
activity, self-care ability and overall wellbeing. The VAS is a 10-cm horizontal line 
anchored with two extremes at the ends. Respondents are asked to make a mark 
across the line at the point that best indicates to which degree they experience the 
actual item (e.g. pain or fatigue). The distance in mm between zero and the mark 
gives a number that quantifies the respondent’s perceived severity of the item. The 
VAS is a valid, reliable and widely used measure for subjective experiences, but the 
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scale has some limitations (202-204). Meaningful use of the VAS requires a cognitive 
understanding of the linear representation of a phenomenon. Hence, individuals with 
poorly developed numerical, graphical or verbal skills may have problems with the 
scoring. The VAS can only be administered in a written form, which is a limitation 
for visually impaired persons, and it is not applicable in telephone interviews. 
(203;205). Further, the VAS assumes that the examined phenomenon may be 
expressed as a linear function. This concept is debatable and the interpretation of 
VAS scores has therefore been discussed (206;207). Additionally, possible 
measurement errors may occur because photocopying may alter the length of the 
VAS line and measuring the distance may be inaccurate (208).  
The NRS is also a 10-cm horizontal line anchored with two extremes at the ends. 
Unlike the VAS, the NRS has fixed boxes, numbered from zero to ten, and the 
respondents are asked to tick the number that best indicate their condition. Hence, 
NRSs can easily be used by visually impaired persons and in telephone interviews. 
Comparisons of VAS and NRS for measuring pain have documented similar 
clinimetric properties. However, the NRS seems to have better sensitivity and is the 
most preferred scale by the respondents (204;205). Consequently, we replaced the 
VAS with NRS in the RCT (paper IV). 
6.1.6 Data analyses 
6.1.6.1 Statistical methods and analyses of quantitative data 
All outcome variables were continuous and results were reported as mean values with 
95% CI of the differences. The 95% CI indicates the interval containing the true 
value with 95% probability; thus showing the uncertainty of the estimate and is 
considered to provide more useful information than the p-value (187). Because p-
values are frequently used when reporting statistical effects of interventions, we have 
also reported the p-values for changes (paper I and III) and differences between 
groups (paper IV). In order to interpret the p-values, the level of significance (-level) 
was set at < 0.05 in all studies, which means less than 5% risk of making a type 1 
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error (i.e. rejecting the null-hypothesis when it is actually true). In paper I, the 
multiple measurements (i.e. including eight outcome variables) may have increased 
the risk of a type I error, and thereby have influenced the validity of the results. 
In papers I and III, paired t-tests were computed to examine changes in outcome 
variables from baseline to follow-ups. Paired t-tests are used to compare the means of 
two groups of measurements, and are only appropriate when there is just one 
observation for each pair of variables (e.g. before and after an intervention). T-tests 
are not suitable to compare multiple observations or to adjust for covariates. If values 
are missing, the mean for that individual will not be calculated. The t-tests assume 
that the variables are normally distributed. 
A superior choice of method when comparing groups at different time points is a 
general linear model, such as repeated measures ANOVA or mixed model repeated 
measures. We therefore used the mixed model repeated measures for estimating 
treatment effects (i.e. between-group differences) in the RCT. This model includes 
the interaction of treatment and time and allows adjustment for baseline values of 
covariates. This type of analysis is robust to missing values, because the patients are 
included at time points with non-missing values only. We applied a parametric 
bootstrap procedure to ascertain the robustness of the findings. (A number of patients, 
equal to the number included in the sample, were drawn from the original data and 
replaced. Estimates from these data were recalculated, and this process was repeated 
5000 times). The model assumptions were assessed using Cook's d (i.e. measuring 
effect of deleting a given observation, for example outliers) and Covratio statistics 
(i.e. measuring the effect of observations on the covariance matrix of the parameter 
estimates) for individuals as well as for the estimated covariance. 
To compare a particular intervention’s different outcomes independent of the 
measuring units, the effects can be standardised in units of standard deviation, 
calculated as change scores within a group or between-group differences. The 
resulting statistical measure is known as the effect size (ES) index (169;177). Cohen 
has defined thresholds to interpret the magnitude of the ES as trivial (< 0.20), small 
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(0.20 – 0.49), moderate (0.50 – 0.79) and large (more than 0.80) (170). In paper I and 
III, ES for the change scores were calculated as SRMs by dividing the mean change 
for each outcome measure by the SD of the change score. In paper IV, the treatment 
effect sizes were calculated as the adjusted between-group difference in scores 
divided by the pooled SD of the baseline scores for each variable (Cohen’s d) 
(168;169).  
In paper III, evidence for the existence of the two EAC subscales was assessed by 
PCA with varimax rotation (172). Components with eigenvalues greater than one 
were considered potentially important. Eigenvalue is an index of the amount of 
variance accounted for by each factor (174). Because the factor structure had been 
determined in previous studies, we might instead have used a confirmatory factor 
analyses to compare the Norwegian version by the original American version of the 
EAC (174;209). 
Internal consistency was assessed by item-total correlations and Cronbach’s alpha. 
The usual rule of thumb is that an item’s correlation with the total score should be 
above 0.20, and that items with lower correlations should be discarded (174). A 
Cronbach’s alpha value of 0.70 is considered acceptable for a scale to be sufficiently 
reliable for use in groups of patients (174;209). To evaluate the construct validity, 
Pearson's correlation coefficient was used to calculate the correlations between the 
instruments. Correlations less than 0.5 were considered low (174;187). 
A limitation of the responsiveness statistics in paper III is that we only assessed the 
change scores and p-values, in which “real change” is not distinguished from 
measurement error. More appropriate statistical methods would have been either the 
Guyatt responsiveness statistic or the receiver operating characteristic curves (ROC 
analyses) (210;211). However, because we did not collect test-retest data, the 
calculation of the responsiveness statistic that takes into account the score variation in 
patients who are stable, was not possible. Further, the absence of an external criterion 
related to whether patients had an important improvement in coping limited the scope 
for ROC analysis in this study. 
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6.1.6.2 Qualitative analyses 
In order to establish trustworthiness in qualitative content analysis, the process of the 
analysis should be described in sufficient detail, so that the readers have a clear 
understanding of how the analysis was carried out and its strengths and limitations 
(180). The process of our data analysis is described in section 4.8.2., and examples of 
quotations used to form the categories are given in table 7. 
Credibility of the findings deals with how well categories and themes cover the data 
(201). Our data comprised 10 focus groups, each interview ranging from 10 to 34 
pages of written texts. Identifying codes, simplifying the data and forming more 
abstract categories that reflected the content in a reliable way was therefore a great 
challenge. Two researchers independently carried out the initial analysis and then 
compared and discussed the results in order to illuminate differences in 
interpretations. Further, the analysis was discussed with a third experienced 
qualitative researcher who had no prior knowledge about the VTP, and therefore 
could question our interpretations in a constructive way. We also had the opportunity 
to discuss coding issues and labelling of categories in a group of co-researchers, 
which is a form of content validation (201).  
6.2 Main results 
6.2.1 Participants’ experiences of the VTP 
The VTP had influenced the participants’ self-understanding and helped them 
integrating their identity as being both ill and healthy. For some participants the most 
important experience had been to recognize themselves as being more than the 
disease. For others it had been important to accept the impact of their illness and the 
accompanying limitations. The program topics and the various methods had given 
them the opportunity to become more aware of and recognize their emotions and 
reflect upon the meaning of these emotions in relation to their current life situation. 
Participants had increased their awareness of own needs, for example the need for 
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setting own limits and allowing themselves to take a break without getting bad 
conscience. A majority of the participants emphasized that the community with others 
with a similar condition, symptoms and emotional reactions as themselves had been 
particularly important. They felt understood without having to explain their 
condition. 
The VTP did not target predefined goals or behavior change. Participants described 
how change happened as a result of increased non-judgmental awareness and 
acceptance of their emotional experiences and habitual patterns. This is in accordance 
with “the paradoxical nature of change” which is outlined in section 2.3.1.2. Instead 
of just continuing to do what they thought was expected of them, they had begun to 
make choices that were consistent with their own needs and values. This was an 
individual and complex process that required time, and for some it had initially 
provoked uncertainty. An important prerequisite for daring to explore own emotional 
reactions and behavior patterns had been the confident relationship with the group 
facilitators, who had the ability to be present, pay attention to and respond to them as 
human beings.  
Some participants described how they had tried to be optimistic and restrain their 
emotional reactions in order to protect themselves from negative feelings and from 
being a burden to others. This might initially have been a useful coping strategy, but 
over time it had placed heavy burdens on their bodies and caused bodily tensions. 
Recent studies have shown that limited awareness of the nuances of emotions and 
lack of ability to recognize and express emotions properly, may leave these emotions 
unresolved, increase emotional distress, inhibit health promoting behavior and 
compromise communication with health care providers (6;60;83). In contrast, 
actively processing and expressing emotions can decrease distress, create 
opportunities for social support, enhance closeness with others and improve 
adjustment to chronic disease over time (6;83;94).  
Two sets of emotions were particularly highlighted in this study; frustration and 
anger, and sadness and sorrow. These were feelings that patients had tried to avoid or 
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not pay attention to, because they had perceived them as negative and unpleasant. To 
acknowledge that anger could be a response to stretching too far, or not paying 
attention to their own needs, had relieved bodily tensions and released energy. 
Likewise, recognition of sorrow for not being able to work or having lost health 
might have been the first step towards accepting how profound these losses were, and 
the beginning of a reorientation process towards finding new and meaningful life 
activities. 
Most participants described the recognition and expression of emotions as positive. 
However, a few were reluctant to disclose their feelings in a group setting. The focus 
on emotions might initially have been unfamiliar, and the intensity by which feelings 
were experienced might have been surprising and sometimes unpleasant or 
frightening. It may be hypothesized that participating in a group intervention with an 
explicit focus on emotions will distress persons with an avoidance oriented coping 
style or persons who have difficulty in identifying and describing emotions (in 
psychological terms referred to as alexithymia) (212). However, only a very few 
participants expressed negative experiences, such as the group being too emotional 
and too focused on mental problems. A few participants also expressed that they had 
been ambivalent to disclosing personal feelings because they had been afraid that 
they could not be handled by the group. 
People with FMS particularly addressed the importance of being recognized as a 
credible patient. Although there were individual variations, the majority of 
participants with FMS had struggled for years to prove that they were ill and to obtain 
a recognized diagnosis. In order to be believed and taken seriously they had had to 
focus more on their symptoms than on the healthy part of themselves. The lack of 
understanding had been accompanied by feelings of shame, inferiority, being 
misunderstood and disbelieved. For some, the experience of distrust had led to 
isolation and a feeling of loneliness. These descriptions of FMS patients' experiences 
of invalidation agree with other studies reporting that FMS is a low prestige diagnosis 
(213), and that the patients feel stigmatized and not taken seriously (57;214). During 
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the VTP, they had been allowed to express these feelings, and the invitation to 
participate in the VTP had legitimized and acknowledged their status as credible 
patients. These findings illuminate the importance of group interventions for FMS 
patients, but do not explain why we did not find any improvements in the FMS group 
in the pre – post-test study (paper I). Although the moderators of the focus group 
interviews encouraged participants to express divergent opinions and experiences, 
group norms may have covered individual differences. One to one interviews might 
have given more in-depth understanding of these individual variations.  
Because the interviews were conducted only two weeks after the VTP was 
completed, participants may have exaggerated the benefits. Other aspects might have 
been discussed if they had experienced over time whether participation in the VTP 
had affected their lives. Finally, we do not know whether those who did not take part 
in the focus groups would have had other and more critical comments. 
From these focus group interviews we concluded that the VTP had influenced 
participants’ emotional wellbeing and adjustment to their illness. Disease symptoms, 
such as pain and fatigue were not particularly addressed in the interviews. Instead 
participants seemed to have changed their focus away from symptoms to how they 
could manage their situation by accepting and recognizing themselves as being both 
ill and healthy, recognizing their emotions and be more aware of their own needs. 
The beneficial influences seemed to have been reinforced by being part of a 
supportive community and by the explicit focus on emotional topics and use of 
awareness exercises. 
6.2.2 Measurement properties of the EAC in Norwegian persons 
with rheumatic diseases
An instruments’ validity can generally not be proved by a single study. Validity 
concerns the degree of confidence we can place on inferences we make about people 
based on their scores from the scale (174). The results from our study show that the 
EAC has evidence for data quality, internal consistency and validity. Further, 
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participation in the VTP improved emotional processing and emotional expression in 
patients with various rheumatic diseases, indicating that the EAC scales may be 
responsive to change. A major limitation of the study is that we did not assess test-
retest reliability, and this is recommended in future studies. 
The EAC was constructed to measure a concept of active, approach-oriented 
emotion-focused coping. The measurement properties of the EAC have previously 
been extensively assessed in samples of healthy students and women with breast 
cancer (101;102;104;215), but not in persons with rheumatic diseases. The quality of 
the data obtained from our studies would therefore depend on the relevance of the 
items for people with arthritis. The high response rate and low levels of missing data 
indicate that the EAC in general is acceptable and applicable. The PCA supported 
two subscales, emotional processing and emotional expression. Two of the items, “I 
realize that my feelings are valid and important” and “I acknowledge my emotions” 
loaded satisfactorily on the emotional processing factor, but might as well have 
contributed to a third factor. These two items had the lowest item-total correlations 
and highest number of missing values, reflecting that they may have been more 
difficult to interpret than the other items. They also had a skewed distribution towards 
high scores, which may reflect a high threshold for saying that one's emotions are not 
valid and acknowledged. The skewed distribution also produced a ceiling effect. 
Consequently, these items limit the content validity, reliability and responsiveness of 
the emotional processing subscale. 
In accordance with findings in previous studies, both EAC scales have high internal 
consistency (101). Using the proposed criteria for Chronbach’s alpha of between 0.70 
and 0.90; the high alpha value for the emotional expression scale may indicate 
redundancy of some of the items (174). However, this criterion has been discussed. 
Terwee and colleagues give a positive rating for Chronbach’s alpha between 0.70 and 
0.95 (209). A shorter version of the EAC, comprising two four-item scales has been 
tested, but the eight-item scales were found to have slightly higher reliability (101), 
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which was the reason for choosing the longer version for this cross-cultural 
adaptation.   
The hypothesis that the EAC scales would be positively related to the approach-
oriented items in the BACQ and uncorrelated with the avoidance-oriented items was 
supported. The inverse correlation between emotional expression and the GHQ-20 
scores supports the hypothesis that the construct of emotional expression is not 
interfered with distress-laden content. Taken together, these findings correspond with 
previous studies, which have concluded that emotional approach coping is 
conceptually different from passive, avoidance-oriented coping and emotion-focused 
coping strategies related to distress (83;101). To further assess construct validity, the 
EAC should be compared with other scales measuring constructs of 
approach/avoidance-oriented and active/passive coping. 
Responsiveness is the ability of an instrument to measure change if it has really 
happened. We hypothesised that the VTP, which explicitly addressed emotional 
topics and encouraged non-judgemental emotional awareness and sharing of 
emotional experiences, would increase emotional processing and expression. We 
therefore assessed the responsiveness of the EAC in four VTP groups. Additionally, 
we tested the EAC in a one-week SMP intervention, which we assumed would not 
produce significant changes in the EAC. As hypothesised, scores in both EAC scale 
increased significantly after the VTP. However, the change in emotional processing 
(mean change 0.27, p < 0.05) was relatively lower than the change in emotional 
expression (mean change 0.37, p < 0.001), which may be due to the high baseline 
scores and the ceiling effect of two items in the emotional processing scale. 
Previously, few studies have examined EAC as an outcome in interventions (215-
218). Considering the limitations of the responsiveness statistics outlined in section 
6.1.6.1, the small number of patients and the short follow-up period, the results 
relating to responsiveness in this study must be interpreted with caution. Further 
studies based on larger samples and longer follow-up periods should be conducted. 
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However, based on these preliminary findings we decided to include the EAC as an 
outcome measure in the RCT. 
It may be questioned whether the EAC is a mediator of other effects, such as 
psychological distress, rather than an outcome, and thus should be considered a 
process measure. To get an indication of the mediating effects of the EAC, we tested 
if changes in the EAC scales were associated with changes in the GHQ-20 and found 
that increasing scores in emotional processing were associated with reduction in 
GHQ-20 in VTP participants. These associations need to be further explored in larger 
samples. 
6.2.3 Clinical effects of the VTP 
Improvements from participation in the VTP were initially evaluated in the pre – 
post-test study (paper I) and effects were further investigated in the RCT (paper IV). 
The RCT confirmed our findings in the pre – post-test study. Persons with 
inflammatory rheumatic joint diseases showed reduced psychological distress and 
fatigue and enhanced self-efficacy, self-care ability and overall wellbeing after VTP 
participation compared to routine care plus a mindfulness CD for individual 
voluntary use. At one-year follow-up, the number of persons with serious 
psychological distress (> 23) in the VTP group was reduced from 13 to 2, compared 
with a reduction of from 10 to 8 in the control group. Furthermore, participants’ 
acknowledgement and understanding of their emotions (emotional processing) was 
increased. 
In addition to the IA patients, the pre – post-test study included persons with FMS. 
The reason for not including FMS patients in the RCT was that no significant 
improvements were found in any variables in this group. IA diagnosis was the main 
predictor of change in psychological distress. These results differ from the first study 
of the VTP in persons with chronic musculoskeletal pain, including FMS, which 
documented significant reduction in psychological distress one year after completion 
(11). The differences may be due to a selection bias or small samples; or they may 
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indicate that other factors than diagnosis may have influenced the results. However, 
our results are in accordance with a review of non-pharmacological interventions in 
patients with FMS, which concluded that the evidence for effects in symptoms and 
psychological distress is limited (123). The review suggests that specific subgroups 
of FMS patients with relatively high levels of psychological distress can benefit from 
tailored CBT interventions offered at an early stage of the disease. Living with pain 
over a long period of time without access to relevant treatment may lead to 
development of maladaptive patterns of coping behaviours that may be hard to 
change. This seems to be supported by the findings in our qualitative study, in which 
participants with FMS described how they had struggled for years to be believed and 
taken seriously. These findings indicate that future studies should investigate effects 
of the VTP in FMS patients with a more recent disease onset. 
The most important findings in our studies are probably the long-term effects of the 
VTP in persons with inflammatory rheumatic joint diseases. In the RCT, significant 
between-group effects were maintained or increased at 12-month follow-up with 
effect sizes ranging from moderate (psychological distress, self-efficacy pain, self-
care ability and fatigue) to high (self-efficacy symptoms). These results are in 
accordance with the previous VTP studies by Haugli and colleagues, who 
documented reduced psychological distress and increased pain coping and self-care 
abilities at one-year follow-up (10;11). The results differ from reported effects of 
most self-management and CBT interventions (section 2.2.5, table 1). In general, 
effects of these interventions are found to be small and tend to decrease over time 
(116;119). However, a few studies have documented beneficial effects on depression, 
anxiety and fatigue of CBT interventions tailored to patients needs in early stages of 
the disease (121;122). A possible interpretation of the lasting improvements in our 
study is that participants may have incorporated new coping strategies into their daily 
lives, consistent with what has been reported in the qualitative study (section 6.2.1). 
These strategies seem to have strengthened their abilities to respond to stressful 
experiences in a more flexible way and make more conscious choices, consistent with 
their personal values. 
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Some explanations may be proposed. The process-oriented nature of the VTP does 
not impose behaviour changes that participants may not be ready for. Rather than 
being targeted toward specific goal attainments, the VTP encourages non-judgmental 
awareness and acceptance of whatever emerges in the present moment, whether being 
pleasant or unpleasant (corresponding with the mindfulness practice). Participants are 
further encouraged to identify their personal values and resources and to find their 
own meaningful answers, and thus take greater responsibility for their life choices 
(corresponding with ACT, see section 2.2.5.3 and 2.3.1.2). This may have 
strengthened their sense of internal control, and may as well have been one of the 
mechanisms that have increased participants’ self-efficacy beliefs.  
Mindfulness-based interventions have become increasingly popular in western 
societies, including Norway, during the last decade. Although also including other 
elements, the basic training in the VTP consists of mindfulness-based awareness 
exercises. The growing body of literature on mindfulness has therefore helped us 
understand possible working mechanisms of the VTP. An example of these 
mechanisms is that one through refined awareness becomes able to observe own 
thoughts, emotions and bodily senses instead of being defined by them. When 
individuals relate to experiences (e.g. pain or emotions) without being them, they will 
in turn experience increased freedom from automatic behavioural patterns and more 
flexibility in how they respond (128). Mindfulness practice is assumed to reduce 
stress and stress-related responses and thereby increasing ability to cope with pain 
and disability and internal motivation for life-style changes, reducing anxiety and 
depression and enriching interpersonal relationships and social connectedness (219). 
Although research is still limited, it has been suggested that mindfulness training may 
positively regulate brain, endocrine and immune function. In a study comparing 
MBSR to a waiting list control group, significant left-sided anterior activation 
(patterns associated with positive emotional experiences) and increased antibody 
titers to influenza vaccine were found in the mindfulness group (220). Clinical studies 
in various populations have supported the use of mindfulness-based training to 
reduce anxiety and depression (134;135;221;222), and in a recent meta-analytic 
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review the effects were found to be rather robust and strong (127). Mindfulness 
practice addresses the distressing experiences that may occur in several chronic 
conditions, such as inflammatory rheumatic diseases and chronic pain conditions. By 
changing the way people relate to these experiences, mindfulness may improve 
general aspects of health and wellbeing (126;127;223).  
In addition to the mindfulness-based exercises, the VTP explicitly addresses 
emotional topics, such as anger, sorrow and joy in three of the sessions. As 
previously stated, there is a growing body of evidence showing that recognising and 
expressing emotions may decrease the stressful impact of negative emotions (for 
example anger and self-blame) (6;82;83). More recently, the role of positive 
emotions, such as joy and interest, have gained increased attention as essential 
elements of optimal function (224-226). Positive emotions are thought to promote 
discovery of novel and creative action, enhance individuals’ personal resources and 
function as a buffer towards negative experiences (224). In the VTP, participants are 
invited to explore and attend to both negative and positive emotions in an open, non-
judgemental way. As hypothesised, the VTP participants significantly increased their 
emotional processing compared with the control group. Interestingly, emotional 
expression improved in both groups at the 12-month follow-up. The fact that the 
control group was interviewed on telephone four times at two-week intervals on three 
occasions during the control period, answering questions about emotional issues, may 
have influenced their perceptions of how they expressed emotions, and thus partly 
explain the improvements in this group.  
Although there has been an increasing focus on the impact of fatigue in patients with 
inflammatory arthritis in recent years (19;27;32;227), only a few studies on 
interventions aimed at improving individuals' ability to cope with fatigue have been 
published. Individual and group CBT-interventions with a special focus on fatigue 
have been found to improve fatigue impact and coping in RA patients (112;113;122), 
but more studies are asked for (228). The VTP did not explicitly address fatigue. 
However, through mindfulness practice the participants learned to be more fully 
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present in their immediate experiences, without making an effort to avoid or change 
them. In addition, the creative exercises used in the VTP were directed at helping 
participants discover more of their health-promoting resources and to make choices 
consistent with their personal values. As described in the qualitative study, 
participants had become more aware of their own needs, allowing themselves to take 
breaks and act more in accordance with own values and choices, instead of 
complying to others expectations. These may have been energy-releasing processes, 
but the associations have to be further explored. Some studies have reported an 
association between fatigue and psychological distress (19;227), and it is possible 
that improvement in psychological distress might have mediated a reduction in 
fatigue or vice versa. This association needs further investigation. 
There are some major limitations to the generalisability of our results. Only a small 
sample of the approached people enrolled in the study, which probably reflects a 
selection bias in the direction of particularly interested persons. Consequently, the 
results cannot be generalised to the whole population of persons with IA (see section 
6.1.2.3). The reasons reported for not participating were multifaceted. Several were 
interested, but the time schedule was not suitable, some could not be absent from 
work, some had family obligations and some felt too ill or too healthy. For some the 
topics and methods in the VTP may have seemed too challenging. The problem of 
self-selection is common for studies of self-management and other psychosocial 
interventions (188;189). Motivation is important in all kind of interventions and 
particularly in interventions that require active participation and personal effort. The 
key question is how people can be reached with information at the time they are 
motivated and in need for this kind of intervention. The majority of participants in 
our studies had relatively long disease duration and high disease impact in terms of 
psychological distress, pain and fatigue, indicating that the VTP is most relevant for 
this group of patients. However, several participants asked why they had not been 
offered to participate in the VTP at an earlier stage, and further studies are needed to 
explore the effects of the VTP in persons with more recent onset disease. 
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Most people who enrolled in the VTP showed high commitment to the intervention. 
They attended between 8 and 10 sessions, and there were very few dropouts, 
indicating that it was feasible for those who enrolled. Since the first groups were 
implemented in 2003, the VTP has routinely been conducted at several rheumatology 
departments, and we know that there are waiting lists for participation. Thus, the 
intervention seems to be more feasible in clinical practice than in research. The VTP 
is not intended to be included in routine care, but to be a complementary intervention 
for people who need to strengthen their abilities to respond to the stressful 
experiences related to their disease. The comparative effectiveness of the VTP and 
less intensive interventions needs to be evaluated in future studies, and shortening of 
the program without compromising its content may be considered. 
 100 
7. Conclusions and Implications 
The studies included in this thesis have documented beneficial clinical effects of the 
VTP in terms of reduced psychological distress and fatigue, and increased self-
efficacy and processing of emotions. The effects were maintained at the 12-month 
follow-up. The qualitative study of experiences from VTP participation illuminated 
how the participants had recognized themselves as being both ill and healthy, 
increased their recognition of own emotions and their awareness of own needs. The 
combination of program topics and methods and being part of a community where 
they felt recognized, seemed to have reinforced the participants' beneficial 
experiences. The process-oriented nature and length of the program had been 
important to create community within the groups. Additionally, the facilitators' 
abilities to be aware and responsive to the participants had been important for 
creating a supportive community. 
The studies have provided the following answers to our specific research questions: 
 Participation in the VTP significantly improved psychological wellbeing (reduced 
psychological distress and increased overall wellbeing), self-efficacy pain and 
symptoms, pain and fatigue in patients with IA. No significant improvements in 
any variables were found in patients with FMS. 
 IA diagnosis and high fatigue scores at baseline were main predictors of reduction 
in psychological distress at one-year follow-up. 
 The VTP had influenced participants' emotional wellbeing and coping behaviour 
by promoting their recognition of themselves as being both ill and healthy, 
increasing their recognition of own emotions and their awareness of own needs. 
 The beneficial influences seemed to have been reinforced by being part of a 
supportive community and by the explicit focus on emotional topics and use of 
mindfulness-based exercises (awareness). 
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 The EAC had evidence for data quality, internal consistency and construct 
validity, but has yet to be assessed for test-retest reliability. 
 Participation in the VTP improved emotion-focused coping strategies as measured 
by the EAC in patients with various rheumatic diseases, indicating that the EAC 
scales are responsive to change.  
 The VTP significantly improved psychological distress, self-efficacy pain and 
symptoms and emotional processing, compared to a routine care control group 
that received a CD with mindfulness-based home exercises 
 The potential for selection bias reduces the generalisability of the results. 
However, based on the robustness of the statistical methods, participants' high 
commitment to the intervention and the long-term effects, it is reasonably to 
conclude that the VTP may be considered a beneficial complement to existing 
treatments in persons with IA, particularly for those who experience heightened 
psychological distress and fatigue. 
Some issues for further research may be suggested: 
The effects the VTP and other psychosocial group interventions should be compared. 
Shorter versions of the VTP may also be adapted and tested. Moreover, the VTP is 
resource-intensive and economic evaluation should be undertaken. Within a national 
Norwegian context, the VTP may be compared to other inpatient and outpatient 
rehabilitation programs. Further studies are also needed to investigate whether certain 
personality factors are associated with better outcomes from this kind of intervention. 
The EAC study may be considered as an initial validation study, and it is further 
important to evaluate the instrument's test-retest reliability. Moreover, studies based 
on larger samples with longer follow-up period and more appropriate statistical 
methods, such as Gyatt responsiveness statistics, are needed for further testing of 
responsiveness. There is reason to believe that the EAC may be more valid as a 
mediator of other psychological and health-related outcomes. Studies of the 
predictive validity of the EAC are therefore recommended. 
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Only patients with rheumatic diseases were included in the study, and the findings 
cannot automatically be transferred to other populations. As similar emotional 
responses may be recognized by patients with other chronic diseases, the program 
may therefore be adapted and tested in other patient groups. 
In summary, this thesis has provided evidence for the health promoting effects of the 
VTP. It is a safe and feasible intervention that can be recommended to persons with 
inflammatory rheumatic joint diseases who are willing to invest time and effort in 
participation. 
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Errata 
Page 13 List of papers 
The title of paper IV should be:  A mindfulness-based group intervention to reduce 
psychological distress and fatigue in patients with inflammatory rheumatic joint diseases: a 
randomised controlled trial.
Page 53 Table 4: The Brief Approach/Avoidance Coping Questionnaire (BACQ) is
included in paper III. 
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Abstract
Background: Chronic rheumatic diseases are painful conditions which are not entirely
controllable and can place high emotional demands on individuals. Increasing evidence has shown
that emotion regulation in terms of actively processing and expressing disease-related emotions are
likely to promote positive adjustment in patients with chronic diseases. The Emotional Approach
Coping Scale (EAC) measures active attempts to acknowledge, understand, and express emotions.
Although tested in other clinical samples, the EAC has not been validated for patients with
rheumatic diseases. This study evaluated the data quality, internal consistency reliability, validity and
responsiveness of the Norwegian version of the EAC for this group of patients.
Methods: 220 patients with different rheumatic diseases were included in a cross-sectional study
in which data quality and internal consistency were assessed. Construct validity was assessed
through comparisons with the Brief Approach/Avoidance Coping Questionnaire (BACQ) and the
General Health Questionnaire (GHQ-20). Responsiveness was tested in a longitudinal pretest-
posttest study of two different coping interventions, the Vitality Training Program (VTP) and a Self-
Management Program (SMP).
Results: The EAC had low levels of missing data. Results from principal component analysis
supported two subscales, Emotional Expression and Emotional Processing, which had high
Cronbach's alphas of 0.90 and 0.92, respectively. The EAC had correlations with approach-oriented
items in the BACQ in the range 0.17-0.50. The EAC Expression scale had a significant negative
correlation with the GHQ-20 of -0.13. As hypothesized, participation in the VTP significantly
improved EAC scores, indicating responsiveness to change.
Conclusion: The EAC is an acceptable and valid instrument for measuring emotional processing
and expression in patients with rheumatic diseases. The EAC scales were responsive to change in
an intervention designed to promote emotion regulation. The instrument has not yet been tested
for test-retest reliability, which is recommended in future studies.
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Background
Chronic rheumatic diseases often have an important
impact on physical, as well as psychological and social
aspects of patients' lives. Such long-term stressors that
have uncontrollable elements can place great emotional
demands on the individual. Research has documented a
high degree of depression, anxiety and psychological dis-
tress in patients with rheumatoid arthritis (RA) and other
rheumatic diseases [1-6].
There are individual differences in how patients cope with
various symptoms and adjust to the burden of the disease.
In early stages of the disease emotional distress is associ-
ated with levels of pain and fatigue, functional status, dis-
ease impact on daily life, life events and perceived social
support [1,7]. The effect of disease-related factors on psy-
chological distress seems to decrease [3,8] and personality
characteristics and individual coping resources appear to
become more important predictors over time [7,9]. Vari-
ous self-management interventions have been developed
to improve patients' ability to cope with the complexity of
symptoms related to their rheumatic disease [10-12].
There is a growing consensus that emotion regulation, in
terms of acknowledging and dealing with negative emo-
tions associated with chronic illness, can contribute to
adjustment [13,14]. However, few interventions explicitly
address patients' emotional response to their disease
[9,15].
The Vitality Training Program (VTP) is a Norwegian group
intervention [16], which has a special focus on awareness
of and reflection upon one's own emotions, thoughts and
bodily experiences. It has produced a reduction in psycho-
logical distress and increased emotional well-being in a
randomized, controlled trial in persons with chronic mus-
culoskeletal pain [17] and in a one-year follow-up of a
non-controlled study for patients with inflammatory
rheumatic diseases [18]. The results shall be further evalu-
ated in a randomized, controlled trial. However, follow-
ing a search of the literature, no acceptable instrument to
measure intervention-related change in patients' coping
strategies related to emotional awareness was found.
The coping literature makes a distinction between prob-
lem-focused and emotion-focused coping strategies [19-
21]. Problem-focused coping includes direct efforts to
alter the demands on the person, whereas emotion-
focused coping includes efforts to regulate emotions asso-
ciated with stressful situations. Research based on earlier
published coping scales has found that use of emotion-
focused coping strategies is often associated with psycho-
logical distress and maladjustment [13,20,22]. However,
there is increasing research on the adaptive nature of
acknowledging, processing, and expressing one's emo-
tions. An ability to approach one's and others' emotions
is seen as crucial to healthy intra- and interpersonal func-
tioning [13-15,23]. This view has also received empirical
support through studies on emotional disclosure inter-
ventions [24-29].
Major problems have been identified in the existing con-
ceptualization and measurement of emotion-focused cop-
ing [13,20,22]. Diverse coping methods, such as
approach-oriented (e.g. seeking social support) and avoid-
ance-oriented (e.g. denial) strategies, have been assessed
with emotion-focused coping items, some of which are
inversely correlated. Emotion-focused coping scales have
also included items related to emotional distress and neg-
ative emotions (e.g. angry, upset, blame myself). Hence,
these earlier measures of emotion-focused coping were
confounded by aspects of psychological health. Stanton et
al [22] developed a construct of emotional approach cop-
ing which does not include distress-related items. Based
on this construct, the Emotional Approach Coping Scale
(EAC) is comprised of two factors [22]: Emotional
Processing, which includes active attempts to acknowl-
edge, explore meanings and come to an understanding of
one's emotions; and Emotional Expression, which
includes active verbal and/or nonverbal attempts to com-
municate or symbolize one's emotional experience. The
EAC has been tested in clinical samples [13], including
patients with chronic myofascial pain [29]. These studies
show that emotional approach coping is inversely related
to psychological distress and can predict better adjust-
ment and less pain and depression over time [13,22,29].
The aim of this study was to evaluate the Norwegian ver-
sion of the EAC in patients with rheumatic diseases. More
specifically, the instrument was tested for data quality,
internal consistency reliability and construct validity in a
cross-sectional study. Responsiveness to change was
assessed using longitudinal data from a pretest-posttest
study that included patients recruited from two different
coping interventions, the VTP and an inpatient Self-Man-
agement Program (SMP).
Methods
Data collection
Recruitment of three different groups of patients took
place in 2007 and all received self-completed question-
naires. For the cross-sectional study, 118 consecutive
patients (group 1) who had a confirmed rheumatological
diagnosis and who attended regular consultations at rheu-
matology inpatient, outpatient or day hospital clinics,
were recruited. Questionnaires were given to patients by
rheumatology nurses at a single data collection point. For
the pretest-posttest study, 49 patients (group 2) attending
four VTP groups and 103 patients (group 3) attending five
diagnosis-specific SMP courses were recruited. Group 2
were given questionnaires by facilitators immediately
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before the first VTP session and were mailed question-
naires after the last session. Group 3 were given the ques-
tionnaires by a nurse at the beginning of the first day of
the SMP and at the end of the last day of the course. Base-
line data from group 2 and 3 and all data from group 1
were used in the cross-sectional study.
Inclusion criteria were adults with confirmed rheumato-
logical diagnosis in the consecutive sample (group 1) and
confirmed rheumatological diagnosis of at least six
months duration and age over 20 years in the two coping
interventions (group 2 and 3). All patients received writ-
ten and oral information regarding the study, and
informed consent was obtained from all patients before
entering the study. Group 1 patients were free to either fill
out the questionnaire or not; questionnaires were sent
back anonymously. This survey was regarded as a compo-
nent of quality assurance and hence ethical approval was
not required. The pretest-posttest study samples partici-
pated in two evaluation studies, which both were
approved by the Regional Committee for Medical Ethics.
Interventions
The VTP aims at helping patients to become more aware
of their internal and external resources in order to cope
with their current life situation. Processing, acknowledg-
ing, and expressing one's emotions are central elements.
Through participation-based teaching and counselling
methods, as well as awareness and relaxation training,
patients learn to accept their thoughts, feelings and bodily
experiences as they are, and respond to their symptoms,
other people, and situations in more adaptive ways. The
VTP lasts for approximately 4 months, involving 10 ses-
sions of process-oriented group learning for 8 to 12
patients with different rheumatic diseases. Each group is
facilitated by two health professionals (nurses, physio-
therapists, occupational therapists or social workers), who
have completed a one-year postgraduate program in the
VTP. The one-week inpatient Self-Management Program
(SMP) is taught in disease specific groups for 16 patients,
consisting of consultation with a rheumatologist, multi-
disciplinary disease specific teaching, physical exercises
and sharing experiences in small groups. The aim of this
intervention is to strengthen the patients' ability to man-
age symptoms, treatment, and physical and psychosocial
life style changes inherent in living with a rheumatic dis-
ease.
Measures
The EAC comprises 16 items that form two subscales;
Emotional Processing (8 items) and Emotional Expres-
sion (8 items). The items have a 4-point scale of "I don't
do this at all", "I do this a little bit", "I do this a medium
amount" and "I do this a lot". The mean item score is cal-
culated for each subscale. The two subscales have satisfac-
tory internal consistency and test-retest reliability in
samples of undergraduate students [22].
The original US version of the EAC underwent a forward
and backward translation [30]. Two Norwegians profi-
cient in English independently translated the question-
naire into Norwegian. One licensed translator, and a
person who was proficient in English carried out the back-
ward translation independently. The forward and back-
ward translations were discussed by the translators, a
psychologist and the research group. Discrepancies
between the various versions were resolved by consensus
in order to achieve conceptual equivalence between the
Norwegian and original US versions of the EAC. The con-
sensus version of the back-translation was mailed to the
original author (ALS) who confirmed semantic equiva-
lence. In the current study, participants were instructed to
complete the items with reference to how they usually
respond to emotions related to their chronic rheumatic
disease.
The Brief Approach/Avoidance Coping Questionnaire
(BACQ) comprises 12 items designed to measure a gen-
eral concept of approach-versus avoidance-oriented cop-
ing. Items have a 5-point Likert scale from "strongly
disagree" to "strongly agree". The BACQ had satisfactory
psychometric properties in a Norwegian population of
primary care patients [31].
The General Health Questionnaire (GHQ-20) comprises
20 items and measures several aspects of psychological
distress during the previous 2 weeks [32,33]. Items have a
4-point scale of "not at all", "no more than usual", "rather
more than usual" and "much more than usual". The total
score ranges from (0) no distress at all to (60) severe dis-
tress. The GHQ has been shown to be valid and reliable
across cultures [34] and the GHQ-20 has been widely
used in Norwegian studies [35,36].
Statistical analyses
Levels of missing data were assessed for the EAC items and
scales. Evidence for the existence of the two EAC subscales
was assessed by principal component analyses (PCA) with
varimax rotation [37]. Components with eigenvalues
greater than one were considered potentially important.
Internal consistency
Internal consistency was assessed by item-total correla-
tions and Cronbach's alpha. For a scale to be sufficiently
reliable for use in groups of patients, an alpha value of
0.70 is considered acceptable [38,39].
Construct validity
Construct validity was assessed by comparing the EAC
scores with the BACQ and GHQ-20 with Pearson's corre-
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lation coefficient [39-41]. We hypothesised that the EAC
scores would be positively related to approach-oriented
items in the BACQ. EAC subscales and the BACQ measure
distinct aspects of coping, and hence correlations with the
BACQ were not expected to be high, but of a low to mod-
erate level (0.3 - 0.6). Because the EAC scales were
designed to be unconfounded by distress-laden content
[22], we expected the correlations with GHQ-20 to be
negative and of a low magnitude under 0.3.
Responsiveness to change
Responsiveness refers to an instrument's ability to meas-
ure change over time [39,42,43]. This was assessed in the
VTP and the SMP samples by the standardized response
mean (SRM). SRMs were calculated by dividing the mean
change scores by the standard deviation (SD) of the
change scores. Effective processing and expression of emo-
tions are more central elements in the VTP than in the
SMP, and hence it was hypothesised that relative to SMP
participants, the VTP participants would have a larger
increase in the EAC scores.
All analyses were performed with SPSS, version 14.0
(SPSS Inc., Chicago, IL, USA).
Results
Data collection
A total of 220 patients were included in the cross-sectional
study; 118 in group 1, 66 (64.1%) in group 2 and 36
(73.5%) in group 3 (table 1). Patients had a mean age of
50.3 (SD 12.63), 165 (75.0%) were women and following
diagnoses were reported: rheumatoid arthritis (58), anky-
losing spondylitis (38), psoriatic arthritis (32), fibromyal-
gia (31), osteoarthritis (25), connective tissue diseases
(11), juvenile rheumatoid arthritis (4) and others (18).
Group 1 patients attending the rheumatology clinic were
more likely to be men and had significantly longer disease
duration than the two others. Group 3 patients attending
the VTP, were significantly younger than the two other
groups. No significant differences were found for other
variables assessed at baseline (table 1).
Statistical analyis
Overall, patients were able to complete the EAC question-
naire without help. There were few missing values, and
these ranged from 1.9% to 5.7% for items relating to Emo-
tional Expression and Emotional Processing, respectively.
Mean item scores (SD) ranged from 2.51 (0.89) to 3.32
(0.66) (table 2).
Principal component analysis yielded two components
with eigenvalues 7.25 and 2.79; a third weak component
had an eigenvalue of 0.97. The first two components
accounted for 62.7% of the total variance. Both compo-
nents had high loadings, the majority (14/16) being over
0.6 and clearly reflecting the two hypothesized domains
of Emotional Expression and Emotional Processing.
Internal consistency
Item-total correlations all exceeded 0.45. Both the EAC
Expression and Processing scales met the Cronbach's
alpha criterion of 0.70.
There were very little missing data at the scale level. Whilst
item scores were generally skewed towards positive levels
of coping, the domain scores were more normally distrib-
uted with means of 2.84 (0.63) and 2.71 (0.63) for Emo-
tional Processing and Emotional Expression, respectively
(table 2). End effects were low; 3 (1.36%); and 0 patients
scored at the floor and 10 (4.55%) and 14 (6.36%) scored
at the ceiling for Emotional Expression and Emotional
Processing, respectively.
Construct validity
As hypothesised the EAC scales had low to moderate cor-
relations with the approach-oriented items in the BACQ.
The EAC Expression scale had significant moderate corre-
lations with the BACQ items "I say so if I am angry or sad"
and "I like to talk to a few chosen people when things get
too much for me", but had only weak correlations with
the other approach-oriented items. The EAC Processing
scale had a significant moderate correlation with the item
"I like to talk to a few chosen people when things get too
much for me" and was only weakly correlated with the
other approach-oriented items (table 3). There were no
significant correlations between the EAC scales and the
avoidance-oriented items in BACQ. The EAC Expression
scale had a low, but significant, negative correlation with
the GHQ-20, such that higher emotional expression was
associated with lower distress, supporting the hypothesis
that the EAC scales are unconfounded of distress-laden
content. The correlation between the EAC Processing scale
and the GHQ-20 was very low and not significant.
Responsiveness to change
Twenty-six (72%) of the included patients in group 2
completed a questionnaire after the VTP. All included
group 3 patients attending the SMP completed a question-
naire after the program. As hypothesised the EAC scores
increased more in the VTP sample than in the SMP sam-
ple. In the VTP sample, there were significant increases in
both EAC Processing and EAC Expression. This group also
showed a significant reduction in GHQ-20 scores. The
SRMs were between 0.40 and 0.73. There were no signifi-
cant changes in the EAC scales in the SMP sample at fol-
low-up, but a significant reduction was found in the
GHQ-20 scores (table 4).
Discussion
This study has translated the EAC to Norwegian following
established guidelines for forward-backwards translation
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[30]. The Norwegian version of the EAC was found to be
acceptable to patients with rheumatic diseases and had
low levels of missing data. The results of PCA show that
the two scales defined by the instrument's authors are sup-
ported empirically. The EAC scales also have good evi-
dence for internal consistency and construct validity. As
hypothesized, the EAC scales were responsive to change in
an intervention designed to promote effective emotion
regulation (VTP), but not in an intervention with less
focus on managing emotions (SMP).
The items "I realize that my feelings are valid and impor-
tant" and "I acknowledge my emotions" had the lowest
item-total correlations. The content of these two items
may be interpreted as reflecting the value of one's emo-
tions. They loaded satisfactorily on the emotional process-
Table 1: Baseline characteristics of patients (n = 220)
Group 1 Group 2 Group 3
Rheumatology Vitality Training Self-Management
clinics (n = 118) Program (n = 36) Program (n = 66)
Age, mean (range) 49.9 (17 - 78) 45.9 (29 - 71)* 53.3 (25 - 86)
Female, n(%) 71 (60.7)** 34 (94.4) 60 (90.9)
Disease duration, mean (range) 10.0 (0 - 47)*** 5.0 (1 - 45) 5.0 (0.5 - 32)
Diagnosis, n (%):
rheumatoid arthritis 48 (41.7) 10 (27.8) 0
ankylosing spondylitis 22 (19.1) 6 (16.7) 19 (15.2)
psoriatic arthritis 20 (17.4) 5 (13.9) 7 (10.6)
fibromyalgia 2 (1.7) 8 (22.2) 21 (31.8)
connective tissue disease 5 (4.3) 0 6 (9.1)
osteoarthritis 1 (0.9) 2 (5.6) 22 (33.3)
juvenile arthritis 3 (2.6) 1 (2.8) 0
others 14 (12.2) 4 (11.1) 0
EACscales:
Emotional Processing 2.78 (0.6) 2.96 (0.6) 2.83 (0.7)
Emotional Expression 2.68 (0.6) 2.60 (0.7) 2.76 (0.6)
BACQ 3.28 (0.4) 3.25 (0.5) 3.15 (0.4)
GHQ - 20 22.01 (9.8) 24.06 (7.8) 22.48 (9.6)
Emotional Processing: 1 = low processing, 4 = high processing
Emotional Expression: 1 = low expression, 4 = high expression
BACQ = Brief Approach/Avoidance Coping Questionnaire: 1 = low approach, 4 = high approach
GHQ - 20 = General Health Questionnaire: 0 = no distress, 60 = high distress
Values are means (SD) for continues variables and frequencies (percentages within sample) for categorical values.
Disease duration = median years since diagnosis.
* significant lower mean than the two other samples (p = 0.027)
** significant lower proportion than the two other samples (p < 0.001)
*** significant higher median than the two other samples (p < 0.001)
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ing factor, but might as well have contributed to a third
factor. Looking at the skewed distributions of these two
items, we also found a ceiling effect, which may reflect a
high threshold for saying that one's emotions are not
valid and acknowledged. There were some missing values
for these items, and hence they may have been more diffi-
cult to interpret for some patients.
Both EAC scales have high internal consistency which fol-
low previous findings [22,29]. The high Cronbach's alpha
for the EAC Expression scale (0.92) may indicate that
some of the items in this scale are unnecessary. An earlier
version of the EAC comprised two four-item scales [22]
which were expanded to eight-item scales. The longer ver-
sion was found to have slightly higher reliability, which
was the reason for choosing the longer-form version for
this cross-cultural adaptation. If the EAC is to be used with
groups of patients, then it might be argued that the four-
item scales will suffice. However, if the instrument is to be
used in clinical practice for assessing individual patients
then the longer-form is recommended since it meets the
minimum criterion of a Cronbach's alpha of 0.90 [44].
Both EAC scales were related to the approach-oriented
items in the BACQ and uncorrelated with the avoidance-
oriented items, supporting construct validity. As expected,
the correlations were strongest between EAC Expression
and the expressive BACQ items. The inverse correlation
between EAC Expression and the GHQ-20 scores supports
the hypothesis that EAC Expression is related to positive
adjustment, rather than dysfunction. From the negative
correlation it may be concluded that the concept of coping
through expressing one's emotions is distinct from psy-
chological distress. Taken together, these findings corre-
spond with previous studies that concluded that
emotional approach coping is conceptually different from
Table 2: Descriptive statistics, component loadings and internal consistency of the EAC (n = 220)
Frequency %
Scale/item Missing (%) Mean (SD) Not at all A little Moderately A lot Component 
loadinga
Cronbach's 
/item-total 
correlation
Emotional 
processingb
2.84 (0.63) - - - - - 0.90
Take time to figure 
out
1 (0.5) 2.79 (0.77) 8 (3.6) 73 (33.2) 100 (45.5) 38 (17.3) 0.71 0.88
Delve into feelings 0 2.62 (0.83) 14 (6.4) 92 (41.8) 79 (35.9) 35 (15.9) 0.81 0.88
Validity/
importance
3 (1.4) 3.28 (0.69) 6 (2.7) 17 (7.7) 105 (47.7) 89 (40.5) 0.58 0.90
Acknowledge 
emotions
5 (2.4) 3.32 (0.66) 0 25 (11.4) 96 (43.6) 94 (42.7) 0.46 0.90
Work on 
understanding
0 2.88 (0.84) 11 (5.0) 64 (29.1) 87 (39.5) 58 (26.4) 0.84 0.88
Explore emotions 2 (0.9) 2.51 (0.89) 30 (13.6) 85 (38.6) 72 (32.7) 31 (14.1) 0.80 0.88
Find way to 
understand
1 (0.5) 2.69 (0.84) 15 (6.8) 82 (37.3) 84 (38.2) 38 (17.3) 0.80 0.88
Look closely at 
reasons
0 2.72 (0.91) 20 (9.1) 72 (32.7) 79 (35.9) 49 (22.3) 0.85 0.88
Emotional 
expressionb
2.71 (0.63) - - - - - 0.92
Take time to 
express
0 2.62 (0.76) 10 (4.5) 89 (40.5) 94 (42.7) 27 (12.3) 0.62 0.91
Let feelings come 
out
0 2.57 (0.84) 21 (9.5) 84 (38.2) 87 (39.5) 28 (12.7) 0.79 0.91
Allow myself to 
express
0 2.75 (0.81) 14 (6.4) 62 (28.2) 110 (50.0) 34 (15.5) 0.85 0.90
Feel free to 
express
0 2.92 (0.84) 15 (6.8) 45 (20.5) 109 (49.5) 51 (23.2) 0.75 0.91
Express feelings I 
have
1 (0.5) 2.77 (0.74) 8 (3.6) 66 (30.0) 113 (51.4) 32 (14.5) 0.86 0.90
Find way to 
express
2 (0.9) 2.80 (0.72) 8 (3.6) 58 (26.4) 122 (55.5) 30 (13.6) 0.62 0.92
Let feelings out 0 2.65 (0.82) 16 (7.3) 85 (38.6) 88 (40.0) 31 (14.1) 0.87 0.90
Get feelings out 1 (0.5) 2.67 (0.77) 13 (5.9) 80 (36.4) 100 (45.5) 26 (11.8) 0.82 0.90
a Emotional expression and emotional processing had eigenvalues of 7.25 and 2.79 respectively
b The two EAC scales are scored from 1-4 where 4 reflects the most frequent use of EAC
BMC Musculoskeletal Disorders 2009, 10:107 http://www.biomedcentral.com/1471-2474/10/107
Page 7 of 9
(page number not for citation purposes)
Table 3: Correlation between the EAC scores, BACQ and GHQ-20 (n = 220)
EAC processing EAC expression
EAC processing - 0.48**
EAC expression 0.48** -
BACQ total 0.29** 0.40**
1 I say so if I am angry or sad 0.18* 0.50**
2 I like to talk to a few chosen people when things get too much for me 0.39** 0.44**
4 I make an active effort to find a solution to my problems 0.26** 0.17*
8 I think something positive could come out of my complaints/problems 0.24** 0.22**
9 I firmly will believe that my problems will decrease 0.08 0.13*
GHQ-20 - 0.01 -0.21*
* p < 0.05, ** p < 0.01
Table 4: Responsiveness of the EAC, BACQ and GHQ-20 in the VTP§ (n = 26) and the SMP§ (n = 66)
Baseline Follow-up Change scores SRM
mean (SD) mean (SD) mean (SD)
EAC processing
VTP (4 months) 3.12 (0.60) 3.39 (0.64) - 0.27 (0.58)* 0.47
SMP (1 week) 2.83 (0.66) 2.93 (0.66) - 0.10 (0.52) 0.19
EAC expression
VTP (4 months) 2.69 (0.64) 3.06 (0.56) - 0.37 (0.53)** 0.70
SMP (1 week) 2.76 (0.63) 2.82 (0.57) - 0.06 (0.45) 0.13
BACQ total
VTP (4 months) 3.41 (0.42) 3.55 (0.46) - 0.14 (0.35) 0.40
SMP (1 week) 3.14 (0.44) 3.22 (0.45) - 0.08 (0.36) 0.22
GHQ-20
VTP (4 months) 24.88 (9.40) 16.23 (9.33) 8.65 (11.80)** 0.73
SMP (1 week) 22.94 (9.96) 17.55 (8.89) 5.39 (7.15)** 0.75
§ VTP = the Vitality Training Program, SMP = the Self Mangement Program
* P < 0.05, ** P < 0.001, Values refer to statistical differences in mean scores between T1 and T2
SD = Standard deviation
SRM = Standardized Response Mean
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passive, avoidance-oriented coping and from other emo-
tion-focused coping strategies related to distress [22,29].
The findings supported the hypothesis that patients with
rheumatic diseases participating in the VTP would
increase their EAC, whereas participants in the SMP would
not. The two interventions are different in both length
and content. In the SMP, active problem-focused coping
strategies are emphasized. Even though emotional distress
is a topic in the program, the participants are not invited
to explore and understand their own emotional coping
strategies to the same degree as in the VTP. Therefore it
was not expected that this one-week program would
change emotion-focused coping strategies. In contrast, the
VTP is a four-month process-oriented program with a spe-
cial focus on emotions, and hence a change in emotion-
focused coping strategies was expected. Both EAC scale
scores improved significantly after the VTP. The smaller,
significant change in EAC Processing may be due to the
relatively high score at baseline, making it difficult to
detect change. There were also a small number of patients
in the VTP sample so the results should be interpreted
with some caution. Few studies have examined EAC as an
outcome or moderator of effects of emotion regulation
interventions [22,28,45-48]. Findings in this study indi-
cate that the EAC may be used as an outcome measure in
interventions for patients with rheumatic diseases where
emotional approach coping is targeted.
A limitation in this study is that the EAC was compared
with only two other measures to assess construct validity
and comparisons with other scales measuring approach/
avoidance-oriented coping and active/passive coping are
recommended. Another limitation is that the instrument
has not yet been tested for test-retest reliability, which is
recommended in future studies. Test-retest data would
also have allowed the calculation of the responsiveness
statistic, which takes account of score variation in patients
who are stable [49]. Receiver operating characteristic
(ROC) curves [50] is a further method of assessing respon-
siveness but the absence of a criterion relating to whether
patients had an important improvement in coping limited
the scope for ROC analysis in this study. The identifica-
tion of patients that have had an important change in
their coping based on clinical or patient judgments can
also facilitate the interpretability of EAC subscale scores
[38]. The short follow-up period in the pretest-posttest
study is a further study limitation, which limits the con-
clusions relating to responsiveness.
Conclusion
The results of this study show that the EAC has evidence
for data quality, internal consistency and validity, but has
yet to be assessed for test-retest reliability, which is recom-
mended in future studies. The study has also shown that
participation in the VTP improves emotion-focused cop-
ing strategies as measured by the EAC in patients with var-
ious rheumatic diseases, showing that the EAC scales are
responsive to change. Further studies based on larger sam-
ples with a longer follow-up period that include other
important psychological and health-related outcome
measures are recommended.
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Appendix  

The Emotional Approach Coping Scale 
SPØRSMÅL OM FØLELSER
Setningene nedenfor handler om hvordan du forholder deg til følelsene dine. Ulike 
situasjoner kan fremkalle ulike følelser med ulik styrke. Her er det ikke noe som er "riktig" 
eller "galt". Velg det svaret som er så sant som mulig FOR DEG; ikke tenk på hva andre ville 
si eller gjøre. Les hver setning nøye og kryss av for hva du vanligvis gjør.
Jeg får følelsene mine fram16
Jeg slipper følelsene mine ut
15.
Jeg finner en måte åuttrykke følelsene mine på
14.
Jeg uttrykker de følelsene jeg har
13.
Jeg føler meg fri til åuttrykke følelsene mine
12.
Jeg tillater meg selv åuttrykke følelsene mine
11.
Jeg lar følelsene mine fåkomme fritt fram
10.
Jeg tar meg tid til å uttrykke følelsene mine
9.
Jeg ser nøye på årsakene til følelsene mine
8.
Jeg finner måter å forståfølelsene mine bedre på
7.
Jeg utforsker følelsene mine
6.
Jeg arbeider med å forståfølelsene mine
5.
Jeg vedstår meg følelsene mine
4.
Jeg er klar over at følelsene mine er sanne og viktige
3.
Jeg går inn i følelsene mine for å forstå dem ordentlig
2.
Jeg tar meg tid til å finne ut hva jeg virkelig føler
1.
I stor grad I middels gradI liten grad Ikke dette i 
det hele tatt
Emotinal Approach Coping Scale (Stanton et al 2000)

